1
|
Boccara F, Sabouret P, Boileau C, Georges JL, Leclercq C, Lesnik P, Bruckert E. Establishing a multi-specialty consensus in the clinical need for hypercholesterolemia management and its implication for patients access to innovative therapies. Panminerva Med 2024; 66:18-26. [PMID: 37851332 DOI: 10.23736/s0031-0808.23.04999-6] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/19/2023]
Abstract
BACKGROUND Increased level of blood LDL-C has a causal and cumulative effect on advancing atherosclerotic cardiovascular diseases (ASCVD). European guidelines for treating high LDL-C levels have been recently updated. However, in France, several challenges (e.g., physician and patient awareness, healthcare management) limit the application of management guidelines. The aim of this study was to understand the current opinions and perceived unmet clinical needs in recognising and managing hypercholesterolemia as an ASCVD risk factor, and to explore consensus around factors that support the effective management of elevated LDL-C. METHODS An expert group of cardiologists, endocrinologists, biology/genetics researchers, and a health technology assessments expert, from France was convened. The current management of hypercholesterolemia and barriers to achieving LDL-C goals in France were discussed and 44 statements were developed. Wider consensus was assessed by sending the statements as a 4-point Likert Scale questionnaire to cardiologists and endocrinologists across France. The consensus threshold was defined as ≥75%. RESULTS A total of 101 responses were received. Consensus was very high (>90%) in 25 (57%) statements, high (≥75%) in 18 (41%) statements and was not achieved (<75%) only in 1 (2%) of statements. Overall, 43 statements achieved consensus. CONCLUSIONS Based on consensus levels, key recommendations for improving current guidelines and approaches to care have been developed. Implementation of these recommendations will lead to better concordance with international treatment guidelines and increase levels of education for healthcare practitioners and patients. In turn, this will improve the available treatment pathways for cardiovascular diseases, potentially creating improved patient outcomes in the future.
Collapse
Affiliation(s)
- Franck Boccara
- Department of Cardiology, Saint-Antoine Research Center, Institut National de la Santé et de la Recherche Médicale (INSERM) UMR S938, Saint-Antoine Hospital, Hôpitaux de l'Est Parisien, Assistance Publique-Hôpitaux de Paris (AP-HP), Sorbonne University, Paris, France -
| | - Pierre Sabouret
- Service of Cardiology, Institute of Cardiology, Pitié-Salpêtrière University Hospital, Sorbonne University, Paris, France
| | - Catherine Boileau
- Department of Genetics, LVTS - Institut National de la Santé et de la Recherche Médicale (INSERM) U1148, Bichat-Claude Bernard Hospital, Assistance Publique-Hôpitaux de Paris (AP-HP), Université Paris Cité, Paris, France
| | - Jean-Louis Georges
- Service of Cardiology, Center Hospitalier de Versailles, Le Chesnay, France
- Annales de Cardiologie et Angéiologie, Elsevier Masson SAS, Issy les Moulineaux, France
| | - Christophe Leclercq
- Service of Cardiology, Rennes University Hospital, University of Rennes, Rennes, France
| | - Philippe Lesnik
- Institut National de la Santé et de la Recherche Médicale (INSERM) UMR_S 1166, Pitié-Salpêtrière University Hospital, Sorbonne University, Paris, France
| | | |
Collapse
|
2
|
Logeart D, Taille Y, Derumeaux G, Gellen B, Sirol M, Galinier M, Roubille F, Georges JL, Trochu JN, Launay JM, Vodovar N, Bauters C, Vicaut E, Mercadier JJ. Patterns of left ventricular remodeling post-myocardial infarction, determinants, and outcome. Clin Res Cardiol 2024:10.1007/s00392-023-02331-z. [PMID: 38261025 DOI: 10.1007/s00392-023-02331-z] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 07/16/2023] [Accepted: 10/20/2023] [Indexed: 01/24/2024]
Abstract
AIM Left ventricular remodeling (LVR) after myocardial infarction (MI) can lead to heart failure, arrhythmia, and death. We aim to describe adverse LVR patterns at 6 months post-MI and their relationships with subsequent outcomes and to determine baseline. METHODS AND RESULTS A multicenter cohort of 410 patients (median age 57 years, 87% male) with reperfused MI and at least 3 akinetic LV segments on admission was analyzed. All patients had transthoracic echocardiography performed 4 days and 6 months post-MI, and 214 also had cardiac magnetic resonance imaging performed on day 4. To predict LVR, machine learning methods were employed in order to handle many variables, some of which may have complex interactions. Six months post-MI, echocardiographic increases in LV end-diastolic volume (LVEDV), LV end-systolic volume (LVESV), and LV ejection fraction (LVEF) were 14.1% [interquartile range 0.0, 32.0], 5.0% [- 14.0, 25.8], and 8.7% [0.0, 19.4], respectively. At 6 months, ≥ 15% or 20% increases in LVEDV were observed in 49% and 42% of patients, respectively, and 37% had an LVEF < 50%. The rate of death or new-onset HF at the end of 5-year follow-up was 8.8%. Baseline variables associated with adverse LVR were determined best by random forest analysis and included stroke volume, stroke work, necrosis size, LVEDV, LVEF, and LV afterload, the latter assessed by Ea or Ea/Ees. In contrast, baseline clinical and biological characteristics were poorly predictive of LVR. After adjustment for predictive baseline variables, LV dilation > 20% and 6-month LVEF < 50% were significantly associated with the risk of death and/or heart failure: hazard ratio (HR) 2.12 (95% confidence interval (CI) 1.05-4.43; p = 0.04) and HR 2.68 (95% CI 1.20-6.00; p = 0.016) respectively. CONCLUSION Despite early reperfusion and cardioprotective therapy, adverse LVR remains frequent after acute MI and is associated with a risk of death and HF. A machine learning approach identified and prioritized early variables that are associated with adverse LVR and which were mainly hemodynamic, combining LV volumes, estimates of systolic function, and afterload.
Collapse
Affiliation(s)
- Damien Logeart
- UMR-S 942 MASCOT, Université Paris Cité and Inserm, Paris, France.
- Assistance Publique Hôpitaux de Paris, Hôpital Lariboisière-Fernand Widal, 75010, Paris, France.
- Université Paris Cité, Paris, France.
| | - Yoann Taille
- Assistance Publique Hôpitaux de Paris, Hôpital Lariboisière-Fernand Widal, 75010, Paris, France
| | - Geneviève Derumeaux
- Assistance Publique Hôpitaux de Paris, Hôpital Henri-Mondor, Créteil, France
| | | | - Marc Sirol
- American Hospital, Neuilly-Sur-Seine, France
| | | | | | | | | | | | - Nicolas Vodovar
- UMR-S 942 MASCOT, Université Paris Cité and Inserm, Paris, France
| | | | - Eric Vicaut
- UMR-S 942 MASCOT, Université Paris Cité and Inserm, Paris, France
- Assistance Publique Hôpitaux de Paris, Hôpital Lariboisière-Fernand Widal, 75010, Paris, France
- Université Paris Cité, Paris, France
| | | |
Collapse
|
3
|
Lasne D, Toussaint-Hacquard M, Delassasseigne C, Bauters A, Flaujac C, Savard P, Mouton C, De Maistre E, Stepanian A, Eschwège V, Delrue M, Georges JL, Gros A, Mansour A, Leroy G, Jouffroy R, Mattei M, Beurton A, Pontis A, Neuwirth M, Nedelec-Gac F, Lecompte T, Curis E, Siguret V, Gouin-Thibault I. Factors Influencing Anti-Xa Assays: A Multicenter Prospective Study in Critically Ill and Noncritically Ill Patients Receiving Unfractionated Heparin. Thromb Haemost 2023; 123:1105-1115. [PMID: 37321244 DOI: 10.1055/s-0043-1770096] [Citation(s) in RCA: 3] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 06/17/2023]
Abstract
BACKGROUND The presence of dextran sulfate (DS) in reagents and the type of blood collection tube (citrate/citrated-theophylline-adenosine-dipyridamole [CTAD]) can lead to discrepancies between unfractionated heparin (UFH) anti-Xa levels. OBJECTIVES To evaluate the extent of the effect (1) of different reagents containing or not containing DS and (2) of the blood collection tubes, on UFH anti-Xa levels, in various clinical situations (NCT04700670). METHODS We prospectively included patients from eight centers: group (G)1, cardiopulmonary bypass (CPB) after heparin neutralization (n = 39); G2, cardiothoracic intensive care unit (ICU) after CPB (n = 35); G3, medical ICU (n = 53); G4, other medical inpatients (n = 38). Blood was collected into citrated and CTAD tubes. Chromogenic anti-Xa assays were centrally performed, using seven reagent/analyzer combinations including two without DS. The association between anti-Xa levels and covariates was tested using a linear mixed-effects model. RESULTS We analyzed 4,546 anti-Xa values from 165 patients. Median anti-Xa levels were systematically higher with reagents containing DS, whatever the patient group, with the greatest effect observed in G1 (0.32 vs. 0.05 IU/mL). Anti-Xa levels were slightly higher in CTAD than in citrate samples, irrespective of the assay. The model showed: (1) a significant dextran-patient group interaction (p < 0.0001), the effect of DS on anti-Xa levels varying from 30.9% in G4 to 296% in G1, and (2) a significant effect of CTAD, varying between patient groups (p = 0.0302). CONCLUSION The variability of anti-Xa levels with a great overestimation of the values, using a reagent containing DS, can lead to different treatment decisions, especially after heparin neutralization by protamine. Clinical consequences of these differences remain to be demonstrated.
Collapse
Affiliation(s)
- Dominique Lasne
- AP-HP, Laboratoire d'hématologie générale, Hôpital Necker, INSERM, Univ. Paris-Saclay, Le Kremlin-Bicêtre, France
| | | | | | - Anne Bauters
- CHU Lille, Institut d'Hématologie-Transfusion, Lille, France
| | - Claire Flaujac
- Laboratoire de Biologie Médicale (Secteur Hémostase), Centre Hospitalier de Versailles, André Mignot, Le Chesnay, France
| | | | - Christine Mouton
- Laboratoire Hématologie, Hôpital Haut-Lévêque, CHU Bordeaux, France
| | | | - Alain Stepanian
- AP-HP, Service d'Hématologie Biologique, Hôpital Lariboisière, Paris Cité University, Paris, France
| | | | - Maxime Delrue
- AP-HP, Service d'Hématologie Biologique, Hôpital Lariboisière, Paris Cité University, Paris, France
| | - Jean-Louis Georges
- Service de réanimation medico-chirurgicale, Centre Hospitalier de Versailles, André Mignot, Le Chesnay, France
| | - Antoine Gros
- Service de réanimation medico-chirurgicale, Centre Hospitalier de Versailles, André Mignot, Le Chesnay, France
| | - Alexandre Mansour
- Department of Anesthesia and Critical Care, Pontchaillou, University Hospital of Rennes; Univ Rennes, CHU Rennes, Inserm, IRSET, Rennes, France
| | | | - Romain Jouffroy
- AP-HP, Service de réanimation adulte, Hôpital Necker, Paris, France
| | - Matthieu Mattei
- Unité d'Anesthésie et Réanimation Cardiaque & Réanimation Médicale Brabois, CHRU Nancy, Nancy, France
| | - Antoine Beurton
- Department of Cardiovascular Anaesthesia and Critical care, Surgical Medical Center Magellan, Haut-Lévêque Hospital, Pessac, France
| | - Adeline Pontis
- Hématologie Biologique, Hôpital Pontchaillou, University Hospital of Rennes, Univ. Rennes, CHU Rennes, Inserm, IRSET, Rennes, France
| | - Marie Neuwirth
- AP-HP, Service d'Hématologie Biologique, Hôpital Lariboisière, Paris Cité University, Paris, France
| | - Fabienne Nedelec-Gac
- Hématologie Biologique, Hôpital Pontchaillou, University Hospital of Rennes, Univ. Rennes, CHU Rennes, Inserm, IRSET, Rennes, France
| | - Thomas Lecompte
- Department of Pharmacy, Faculté de médecine, Namur Thrombosis and Hemostasis Center (NTHC), Namur Research Institute for Life Sciences (NARILIS), Université de Lorraine & Université de Namur, Namur, Belgium
- Hématologie Biologique, Hôpital Pontchaillou University Hospital of Rennes, Rennes, France
| | - Emmanuel Curis
- UR 7537 BioSTM, faculté de pharmacie de Paris, université Paris Cité, Paris, France
- Service d'Hématologie Biologique, Hôpital Lariboisière, AP-HP, Paris, France
| | - Virginie Siguret
- AP-HP, Service d'Hématologie Biologique, Hôpital Lariboisière, Paris Cité University, Paris, France
| | - Isabelle Gouin-Thibault
- Hématologie Biologique, Hôpital Pontchaillou, University Hospital of Rennes, Univ. Rennes, CHU Rennes, Inserm, IRSET, Rennes, France
| |
Collapse
|
4
|
Raphalen JH, Soumagnac T, Delord M, Bougouin W, Georges JL, Paul M, Legriel S. Long-term heart function in cardiac-arrest survivors. Resusc Plus 2023; 16:100481. [PMID: 37859632 PMCID: PMC10582774 DOI: 10.1016/j.resplu.2023.100481] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/22/2023] [Revised: 09/21/2023] [Accepted: 09/22/2023] [Indexed: 10/21/2023] Open
Abstract
Purpose To assess outcomes and predictors of long-term myocardial dysfunction after cardiac arrest (CA) of cardiac origin. Methods We retrospectively included consecutive, single-center, prospective-registry patients who survived to hospital discharge for adult out-of-hospital and in-hospital CA of cardiac origin in 2005-2019. The primary objective was to collect the 1-year New York Heart Association Functional Class (NYHA-FC) and major adverse cardiovascular events (MACE). Results Of 135 patients, 94 (72%) had their NYHA-FC determined after 1 year, including 75 (75/94, 80%) who were I, 17 (17/94, 18%) II, 2 (2/94, 2%) III, and none IV. The echocardiographic left ventricular ejection fraction was abnormal in 87/130 (67%) patients on day 1, 52/123 (42%) at hospital discharge, and 17/52 (33%) at 6 months. During the median follow-up of 796 [283-1975] days, 38/119 (32%) patients experienced a MACE. These events were predominantly related to acute heart failure (13/38) or ischemic cardiovascular events (16/38), with acute coronary syndrome being the most prevalent among them (8/16). Pre-CA cardiovascular disease was a risk factor for 1-year NYHA-FC > I (P = 0.01), absence of bystander cardiopulmonary resuscitation was significantly associated with NYHA-FC > I at 1 year. Conclusion Most patients had no heart-failure symptoms a year after adult out-of hospital or in-hospital CA of cardiac origin, and absence of bystander cardiopulmonary resuscitation was the only treatment component significantly associated with NYHA-FC > I at 1 year. Nearly a third experienced MACE and the most common types of MACE were ischemic cardiovascular events and acute heart failure. Early left ventricular dysfunction recovered within 6 months in half the patients with available values.
Collapse
Affiliation(s)
- Jean-Herlé Raphalen
- Intensive Care Unit, Necker University Hospital, Assistance Publique-Hôpitaux de Paris, 149 rue de Sèvres, 75015 Paris, France
| | - Tal Soumagnac
- Intensive Care Unit, Necker University Hospital, Assistance Publique-Hôpitaux de Paris, 149 rue de Sèvres, 75015 Paris, France
| | - Marc Delord
- Clinical Research Center, Versailles Hospital, 77 rue de Versailles, 78150 Le Chesnay, France
- Department of Population Health Sciences, Faculty of Life Sciences & Medicine, King’s College London, London, United Kingdom
| | - Wulfran Bougouin
- Intensive Care Unit, Jacques Cartier Hospital, 6 Av. du Noyer Lambert, 91300 Massy, France
- INSERM U970, Team 4, Sudden Death Expertise Center, 75015 Paris, France
| | - Jean-Louis Georges
- Cardiology Department, Versailles Hospital, 77 rue de Versailles, 78150 Le Chesnay, France
| | - Marine Paul
- Intensive Care Unit, Versailles Hospital, 77 rue de Versailles, 78150 Le Chesnay, France
| | - Stéphane Legriel
- Intensive Care Unit, Versailles Hospital, 77 rue de Versailles, 78150 Le Chesnay, France
- UVSQ, INSERM, Paris-Saclay University, CESP, PsyDev Team, 94800 Villejuif, France
| |
Collapse
|
5
|
Georges JL. [Intensive cardiac care miscellaneous]. Ann Cardiol Angeiol (Paris) 2023; 72:101693. [PMID: 37866878 DOI: 10.1016/j.ancard.2023.101693] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/24/2023]
Affiliation(s)
- Jean-Louis Georges
- service de cardiologie, Centre Hospitalier de Versailles, Le Chesnay, Rédacteur en chef adjoint, coordinateur du numéro spécial « CNCH » des Annales de Cardiologie Angéiologie..
| |
Collapse
|
6
|
Castro A, Gilles F, Marrakchi S, Wajchert T, Rouvier P, Cohen-Aubart F, Gibault-Genty G, Georges JL. [Cardiac sarcoidosis revealed by recurrent ventricular tachycardia]. Ann Cardiol Angeiol (Paris) 2023; 72:101644. [PMID: 37677913 DOI: 10.1016/j.ancard.2023.101644] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/08/2023] [Accepted: 08/16/2023] [Indexed: 09/09/2023]
Abstract
Sarcoidosis is an inflammatory disease whose diagnosis is suggested by clinical and paraclinical signs and confirmed by histological evidence showing granulomatosis without caseous necrosis. The clinical presentation is sometimes misleading and the diagnosis difficult to confirm. We report here the case of a young woman with cardiac sarcoidosis of difficult diagnosis, revealed by a myocardial infarction with normal coronary angiography and recurrent ventricular tachycardia. Multimodal imaging, combined with left ventricular endomyocardial biopsies guided by electrophysiological analysis and endocavitary mapping, finally confirmed the diagnosis, and allowed effective medical treatment.
Collapse
Affiliation(s)
- Alois Castro
- Service de cardiologie, Centre Hospitalier de Versailles, Hôpital André Mignot, Le Chesnay Rocquencourt, Paris, France
| | - Floriane Gilles
- Service de cardiologie, Centre Hospitalier de Versailles, Hôpital André Mignot, Le Chesnay Rocquencourt, Paris, France
| | - Sonia Marrakchi
- Service de cardiologie, Centre Hospitalier de Versailles, Hôpital André Mignot, Le Chesnay Rocquencourt, Paris, France; Service de rythmologie, Groupe Hospitalier Universitaire de la Pitié Salpêtrière, Assistance Publique-Hôpitaux de Paris, Paris, France
| | - Thibaut Wajchert
- Service de cardiologie, Centre Hospitalier de Versailles, Hôpital André Mignot, Le Chesnay Rocquencourt, Paris, France
| | - Philippe Rouvier
- Service d'anatomie et cytologie pathologiques, Groupe Hospitalier Universitaire de la Pitié Salpêtrière, Assistance Publique- Hôpitaux de Paris, Paris, France
| | - Fleur Cohen-Aubart
- Service de médecine interne, Groupe Hospitalier Universitaire de la Pitié Salpêtrière, Assistance Publique- Hôpitaux de Paris, Paris, France
| | - Géraldine Gibault-Genty
- Service de cardiologie, Centre Hospitalier de Versailles, Hôpital André Mignot, Le Chesnay Rocquencourt, Paris, France
| | - Jean-Louis Georges
- Service de cardiologie, Centre Hospitalier de Versailles, Hôpital André Mignot, Le Chesnay Rocquencourt, Paris, France.
| |
Collapse
|
7
|
Gilles F, Nicot F, Boyer C, Georges JL. Acute myocardial damage after electrical injury assessed by MRI. BMJ Case Rep 2023; 16:e257010. [PMID: 37848275 PMCID: PMC10583039 DOI: 10.1136/bcr-2023-257010] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/19/2023] Open
Abstract
Electrical injuries are not uncommon, and electrical shock-induced cardiac damage can be life-threatening. We present the case of a young patient who suffered from acute myocardial damage due to an occupational electric shock. Myocardial damage was assessed by very early (day 4) and repeated (up to month 18) MRI. Clinical management and patient risk estimation in such a setting are challenging because data on similar non-lethal cases and practice recommendations are scarce in the literature.
Collapse
Affiliation(s)
- Floriane Gilles
- Cardiology, Centre Hospitalier de Versailles, Le Chesnay Rocquencourt, France
| | - Florence Nicot
- Cardiology, Centre Hospitalier de Versailles, Le Chesnay Rocquencourt, France
| | - Clément Boyer
- Cardiology, Centre Hospitalier de Versailles, Le Chesnay Rocquencourt, France
| | - Jean-Louis Georges
- Cardiology, Centre Hospitalier de Versailles, Le Chesnay Rocquencourt, France
| |
Collapse
|
8
|
Maurizot A, Chabay S, Roger G, Tapiero S, Georges JL, Flaujac C, Paul M, Roche A, Bruneel F, Ferré A. Incidence of deep venous thrombosis in COVID-19 critically ill patients treated with intermediate-dose of heparin for thromboprophylaxis: The COVIDOP-DVT observational study. Vascular 2023:17085381231165083. [PMID: 37009990 PMCID: PMC10071186 DOI: 10.1177/17085381231165083] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 04/04/2023]
Abstract
INTRODUCTION The high prevalence of deep vein thrombosis (DVT) in patients admitted to intensive care unit (ICU) for COVID-19-related acute respiratory distress syndrome (ARDS) would justify systematic screening of these patients or higher therapeutic dose of heparin for thromboprophylaxis. MATERIAL AND METHOD We performed a systematic echo-Doppler of the lower limb proximal veins during the first 48 h (visit 1) and from 7 to 9 days after visit 1 (visit 2) in consecutive patients admitted to the ICU of a university-affiliated tertiary hospital for severe proven COVID-19 during the second wave. All patients received intermediate-dose heparin (IDH). The primary objective was to determine DVT incidence on venous Doppler ultrasound. Secondary objectives were to determine whether the presence of DVT modifies the anticoagulation regimen, the incidence of major bleeding according to International Society on Thrombosis and Haemostasis (ISTH) criteria, and the mortality rate of patients with and without DVT. RESULTS We included 48 patients (30 [62.5%] men) with a median age of 63 years [IQR, 54-70]. The prevalence of proximal deep vein thrombosis was 4.2% (2/48). In these two patients, after DVT diagnosis, anticoagulation was changed from intermediate to curative dose. Two patients (4.2%) had a major bleeding complication according to ISTH criteria. Among the 48 patients, 9 (18.8%) died before hospital discharge. No DVT or pulmonary embolism was diagnosed in these deceased patients during their hospital stay. CONCLUSION In critically ill patients with COVID-19, management with IDH results in a low incidence of DVT. Although our study is not designed to demonstrate any difference in outcome, our results do not suggest any signal of harm when using intermediate-dose heparin (IDH) COVID-19 with a frequency of major bleeding complications less than 5%.
Collapse
Affiliation(s)
- Aurélien Maurizot
- Vascular Medicine Unit, Cardiology Department, 26938Versailles Hospital, Le Chesnay, France
| | - Simon Chabay
- Vascular Medicine Unit, Cardiology Department, 26938Versailles Hospital, Le Chesnay, France
| | - Guillaume Roger
- Vascular Medicine Unit, Cardiology Department, 26938Versailles Hospital, Le Chesnay, France
| | - Stéphanie Tapiero
- Vascular Medicine Unit, Cardiology Department, 26938Versailles Hospital, Le Chesnay, France
| | | | - Claire Flaujac
- Haemostasis Unit, Medical Biology Department, 26938Versailles Hospital, Le Chesnay, France
| | - Marine Paul
- Intensive Care Unit, 26938Versailles Hospital, Le Chesnay, France
| | - Anne Roche
- Intensive Care Unit, 26938Versailles Hospital, Le Chesnay, France
| | - Fabrice Bruneel
- Intensive Care Unit, 26938Versailles Hospital, Le Chesnay, France
| | - Alexis Ferré
- Intensive Care Unit, 26938Versailles Hospital, Le Chesnay, France
| |
Collapse
|
9
|
Georges JL, Gaulupeau V, Chanut A, Merceron A, Delaroche-Vernet S, Harboun M, Chayeb S, Sadeg O, Aribi EH, Galindo G, Sekour K, Bornand A, Romain D. [Management of congestive heart failure in the elderly after hospitalization for acute decompensation Interest of a dedicated territorial geriatric network ; the GERICCO-78 study]. Ann Cardiol Angeiol (Paris) 2022; 71:259-266. [PMID: 36041961 DOI: 10.1016/j.ancard.2022.08.002] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/14/2022] [Accepted: 08/05/2022] [Indexed: 06/15/2023]
Abstract
AIMS Heart failure (HF) is the leading cause of hospitalisation in the elderly in France. Early rehospitalisations are common, often through an emergency department. The aim of this study was to assess the impact of a primary care-hospital coordination network, with interventions by coordination nurses (IDEC), on the rehospitalisations after a first hospitalisation for acute decompensation in frail elderly HF patients. METHODS From 01/10/2019 to 01/10/2021, 237 patients aged > 75 years with frailty criteria, hospitalised in 8 departments of 5 private or public hospitals in the Yvelines Sud health territory were followed by an IDEC (hospital visit, telephone contacts, home visit(s)) within 3 months of their return home. This prospective observational study analysed the rate of consultations to the emergency room, rehospitalisations (total and for acute HF), and the number of events avoided at 90 days after discharge. RESULTS The mean age of the patients was 87 years, 54% were women, 68% had a left ventricular ejection fraction > 40%, and 70% had atrial fibrillation. Non-cardiac comorbidities were very frequent. At 3-month follow-up, mortality was 9.3% (22/237), only 27 patients (11.3%) consulted the emergency room for acute HF, and the rehospitalisation rate for HF was 19.8%, without difference according to left ventricular ejection fraction. A consultation to the emergency room or a rehospitalisation for heart failure could be avoided for 10% of patients. CONCLUSION This study suggests that a primary care-hospital coordination network with dedicated coordination nurses is useful for the management of very elderly frail patients following hospitalisation for heart failure, limiting visits to the emergency room and rehospitalisations.
Collapse
Affiliation(s)
- Jean-Louis Georges
- Service de Cardiologie, Centre Hospitalier de Versailles, Hôpital André Mignot, 177 rue de Versailles, 78157, Le Chesnay-Rocquencourt, France.
| | - Violaine Gaulupeau
- Service de Cardiologie, Centre Hospitalier de Versailles, Hôpital André Mignot, 177 rue de Versailles, 78157, Le Chesnay-Rocquencourt, France
| | - Anais Chanut
- Infirmière Coordinatrice, Cellule de coordination ville-hôpital, et réseau REPY, Centre Hospitalier de Versailles, Le Chesnay-Rocquencourt, France
| | - Annick Merceron
- Infirmière Coordinatrice, Cellule de coordination ville-hôpital, et réseau REPY, Centre Hospitalier de Plaisir, Plaisir, France
| | - Sophie Delaroche-Vernet
- Infirmière Coordinatrice, Cellule de coordination ville-hôpital, et réseau REPY, Centre Hospitalier de Versailles, Le Chesnay-Rocquencourt, France
| | - Marc Harboun
- Service de gériatrie aiguë et soins de suite gériatrique, Hôpital Privé de la Porte Verte, Versailles, France
| | - Samir Chayeb
- Service de Cardiologie, Centre Hospitalier de Rambouillet, Rambouillet, France
| | - Ouali Sadeg
- Service de gériatrie aiguë , Centre Hospitalier de Plaisir, Plaisir, France
| | - El Heddi Aribi
- Service de soins de suite gériatriques, Centre Hospitalier de Plaisir, Plaisir, France
| | - Géraldine Galindo
- Service de gériatrie aiguë, Centre Hospitalier de Rambouillet, Rambouillet, France
| | - Kaci Sekour
- Service de médecine et soins de suite gériatriques, Centre Hospitalier de la Mauldre, Jouars Pontchartrain, France
| | - Anne Bornand
- Service de gériatrie aiguë, Pôle de gériatrie, Centre Hospitalier de Versailles, Hôpital André Mignot, Le Chesnay-Rocquencourt, France
| | - Delphine Romain
- Service de soins de suite gériatriques, Pôle de gériatrie, Centre Hospitalier de Versailles, Hôpital Richaud, Versailles, France
| |
Collapse
|
10
|
Assayag F, Georges JL, Chabay S, Lancien S, Flaujac C, Azarian R, de Villepin EG, Tapiéro S, Livarek B, Koukabi M, Maurizot A. [Home treatment of low-risk pulmonary embolism patients : Efficacy and safety of an outpatient program including the general practitioner]. Ann Cardiol Angeiol (Paris) 2022; 71:245-251. [PMID: 35940966 DOI: 10.1016/j.ancard.2022.06.015] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/17/2022] [Accepted: 06/29/2022] [Indexed: 06/15/2023]
Abstract
AIM Outpatient treatment (OT) of patients with low-risk pulmonary embolisms (PE) is recommended. A multidisciplinary OT program including the general practitioner (GP) has been implemented at Versailles hospital in 2019. The objectives of the study were to assess the feasibility, safety and acceptability of the program. MATERIAL AND METHODS The feasibility of, and the inclusion criteria for OT were defined from a retrospective cohort study of PE patients carried out in 2018. In the prospective study, consecutive patients consulting in the emergency department between 2019 and 2021 with confirmed PE were eligible for OT if they had sPESI and HESTIA scores equal to 0, normal troponin and NT-pro-BNP levels, and no right ventricular dilation on imaging. PEs associated with COVID were excluded. The OT program included 4 appointments within 3 months, including 2 with the GP. Events (death, recurrence of PE or venous thromboembolism, bleeding, rehospitalisation) were collected at 3-month follow-up. RESULTS In the retrospective study, 19% of the 138 PE patients seen in the emergency department were eligible for OT. No complication occurred at Day 90. In the prospective study, 313 consecutive patients with confirmed PE in the emergency department were included, 66 (21%) were eligible for OT. Overall, 43 patients (14%) received OT (39 eligible) and 27 patients eligible for OT were hospitalised (92% because of pulmonary infarction). At 3-month follow-up, there were no death, no recurrence of thromboembolism, and one patient has been early hospitalised for COVID; 3 female patients treated with rivaroxaban had minor bleeding (heavy menstrual bleeding). The satisfaction rate of general practitioner was 95%. CONCLUSIONS This study confirms the feasibility and safety of our OT program for low-risk EP patients, centered on the general practitioner. It reduces the time spent in the emergency department, reduces hospitalisations and strengthens the city-hospital link for care.
Collapse
Affiliation(s)
- Franck Assayag
- Service de cardiologie, Centre Hospitalier de Versailles, Hôpital André Mignot, Le Chesnay-Rocquencourt, France; Service d'accueil des urgences, Centre Hospitalier de Versailles, Hôpital André Mignot, Le Chesnay-Rocquencourt, France.
| | - Jean-Louis Georges
- Service de cardiologie, Centre Hospitalier de Versailles, Hôpital André Mignot, Le Chesnay-Rocquencourt, France
| | - Simon Chabay
- Unité de Médecine Vasculaire, Service de Cardiologie, Centre Hospitalier de Versailles, Hôpital André Mignot, Le Chesnay-Rocquencourt, France
| | - Solène Lancien
- Service d'accueil des urgences, Centre Hospitalier de Versailles, Hôpital André Mignot, Le Chesnay-Rocquencourt, France
| | - Claire Flaujac
- Laboratoire de biologie médicale - secteur d'hémostase, Centre Hospitalier de Versailles, Hôpital André Mignot, Le Chesnay-Rocquencourt, France
| | - Reza Azarian
- Service de pneumologie, Centre Hospitalier de Versailles, Hôpital André Mignot, Le Chesnay-Rocquencourt, France
| | - Eve Galouzeau de Villepin
- Service d'accueil des urgences, Centre Hospitalier de Versailles, Hôpital André Mignot, Le Chesnay-Rocquencourt, France
| | - Stéphanie Tapiéro
- Unité de Médecine Vasculaire, Service de Cardiologie, Centre Hospitalier de Versailles, Hôpital André Mignot, Le Chesnay-Rocquencourt, France
| | - Bernard Livarek
- Service de cardiologie, Centre Hospitalier de Versailles, Hôpital André Mignot, Le Chesnay-Rocquencourt, France
| | - Mehrsa Koukabi
- Service d'accueil des urgences, Centre Hospitalier de Versailles, Hôpital André Mignot, Le Chesnay-Rocquencourt, France
| | - Aurélien Maurizot
- Unité de Médecine Vasculaire, Service de Cardiologie, Centre Hospitalier de Versailles, Hôpital André Mignot, Le Chesnay-Rocquencourt, France
| |
Collapse
|
11
|
Combaret N, Liabot Q, Deiri M, Lhermusier T, Boiffard E, Filippi E, Roule V, Georges JL, Manzo-Silberman S, Fluttaz A, Marliere S, Souteyrand G, Pereira B, Cassagnes L, Motreff P. Characteristics and Prognosis of Patients With Fibromuscular Dysplasia in a Population of Spontaneous Coronary Artery Dissections (from the French Registry of Spontaneous Coronary Artery Dissections "DISCO"). Am J Cardiol 2022; 175:38-43. [PMID: 35562298 DOI: 10.1016/j.amjcard.2022.04.007] [Citation(s) in RCA: 4] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 12/28/2021] [Revised: 03/22/2022] [Accepted: 04/05/2022] [Indexed: 11/01/2022]
Abstract
Spontaneous coronary artery dissection (SCAD) and fibromuscular dysplasia (FMD) are pathologies that appear to be closely related. This study compares the characteristics of the FMD population to the non-FMD population in a SCAD cohort. It thus assesses the involvement of the FMD phenotype in a SCAD population. From the data of the French DISCO registry, we included patients with a diagnosis of SCAD and in whom a search for FMD was performed. We collected the following characteristics of this population: the clinical and angiographic presentation, the data concerning the management, and the events occurring during the follow-up. In the 373 SCADs confirmed in the DISCO registry, we obtained imaging data for 340 of them. FMD was found in 45% of cases. The mean age was higher in the FMD group, 53.2 ± 8.8 years, versus 50.1 ± 11 years in the non-FMD group. High blood pressure and postmenopausal status were significantly higher in the FMD group. Clinical presentation, angiographic data, and management were comparable. The major adverse cardiac event rate and recurrence rate were not different between the 2 groups after 1 year of follow-up. In conclusion, we confirmed a 45% prevalence of FMD in the SCAD population. The median age was higher in the FMD group, suggesting that FMD may develop over time. The rate of major adverse cardiac events and recurrence were similar in the FMD group versus the non-FMD group after 1 year of follow-up.
Collapse
Affiliation(s)
- Nicolas Combaret
- Department of Cardiology, Clermont-Ferrand University Hospital Center, Centre National de la Recherche Scientifique, Clermont Auvergne University, Clermont-Ferrand, France.
| | - Quentin Liabot
- Department of Cardiology, Clermont-Ferrand University Hospital Center, Centre National de la Recherche Scientifique, Clermont Auvergne University, Clermont-Ferrand, France
| | - Mays Deiri
- Department of Radiology, Clermont-Ferrand University Hospital Center, Centre National de la Recherche Scientifique, Clermont Auvergne University, Clermont-Ferrand, France
| | | | - Emmanuel Boiffard
- Department of Cardiology, Vendée Hospital center, La Roche-sur-Yon, France
| | - Emmanuelle Filippi
- Department of Cardiology, General Hospital of Atlantic Brittany, Vannes, France
| | - Vincent Roule
- Department of Cardiology, Caen University Hospital, Caen, France
| | - Jean-Louis Georges
- Department of Cardiology, Centre Hospitalier de Versailles, Le Chesnay-Rocquencourt, France
| | | | - Arnaud Fluttaz
- Department of Cardiology, Centre Hospitalier Metropole Savoie, Chambery, France
| | - Stéphanie Marliere
- Department of Cardiology, Grenoble University Hospital, Grenoble, France
| | - Géraud Souteyrand
- Department of Cardiology, Clermont-Ferrand University Hospital Center, Centre National de la Recherche Scientifique, Clermont Auvergne University, Clermont-Ferrand, France
| | - Bruno Pereira
- Biostatistics Unit (Direction de la Recherche Clinique et de l'Innovation DRCI), Clermont-Ferrand University Hospital Center, Centre National de la Recherche Scientifique, Clermont Auvergne University, Clermont-Ferrand, France
| | - Lucie Cassagnes
- Department of Radiology, Clermont-Ferrand University Hospital Center, Centre National de la Recherche Scientifique, Clermont Auvergne University, Clermont-Ferrand, France
| | - Pascal Motreff
- Department of Cardiology, Clermont-Ferrand University Hospital Center, Centre National de la Recherche Scientifique, Clermont Auvergne University, Clermont-Ferrand, France
| |
Collapse
|
12
|
Le Bras A, Puymirat E, Rabetrano H, Cayla G, Simon T, Steg G, Montalescot G, Varenne O, Bonello L, Coste P, Delarche N, Georges JL, Chassaing S, Letocart V, Chatellier G, Danchin N, Durand-Zaleski I. Economic evaluation of fractional flow reserve-guided versus angiography-guided multivessel revascularisation in ST-segment elevation myocardial infarction patients in the FLOWER-MI randomised trial. EUROINTERVENTION 2022; 18:235-241. [PMID: 35191838 PMCID: PMC9980404 DOI: 10.4244/eij-d-21-00867] [Citation(s) in RCA: 3] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/23/2022]
Abstract
BACKGROUND In patients with ST-segment elevation myocardial infarction (STEMI) who have multivessel disease, the FLOWER-MI trial found no significant clinical benefit to fractional flow reserve (FFR)-guided percutaneous coronary intervention (PCI) compared to angiography-guided PCI. AIMS Our aim was to estimate the cost-effectiveness and cost-utility of FFR-guided PCI, the secondary endpoint of the FLOWER-MI trial. METHODS Costs, major adverse cardiovascular events (composite of all-cause death, non-fatal myocardial infarction [MI], and unplanned hospitalisation leading to urgent revascularisation), and quality-adjusted life years were calculated in both groups. The incremental cost-effectiveness and cost-utility ratios were estimated. Uncertainty was explored by probabilistic bootstrapping. The analysis was conducted from the perspective of the health care provider with a time horizon of one year. RESULTS At one year, the average cost per patient was 7,560€ (±2,218) in the FFR-guided group and 7,089€ (±1,991) in the angiography-guided group (p-value<0.01). The point estimates for the incremental cost-effectiveness and cost-utility ratios found that the angiography-guided strategy was cost saving and improved outcomes, with a probabilistic sensitivity analysis confirming dominance. CONCLUSIONS The FFR-guided strategy at one year is unlikely to be cost effective compared to the angiography-guided strategy on both clinical and quality of life outcomes.
Collapse
Affiliation(s)
- Alicia Le Bras
- Unité de Recherche Clinique en Économie de la Santé, Hôpital Hôtel Dieu AP-HP, 1 Parvis Notre-Dame, 75004 Paris, France
| | - Etienne Puymirat
- Department of Cardiology, Hôpital Européen Georges Pompidou AP-HP, Paris, France,Université de Paris, Paris, France,French Alliance for Cardiovascular Trials (FACT), Paris, France
| | - Hasina Rabetrano
- Clinical Research Unit Eco Ile de France, Hôpital Hôtel Dieu AP-HP, Paris, France
| | | | - Tabassome Simon
- French Alliance for Cardiovascular Trials (FACT), Paris, France,Department of Clinical Pharmacology, Hôpital Saint Antoine AP-HP, Paris, France,Université Pierre et Marie Curie (UPMC), Paris, France
| | - Gabriel Steg
- French Alliance for Cardiovascular Trials (FACT), Paris, France,Université Paris-Diderot, Sorbonne Paris Cité, Paris, France,Hôpital Bichat – Claude Bernard AP-HP, Paris,France
| | - Gilles Montalescot
- ACTION Groupe, Institut de Cardiologie (AP-HP) and INSERM UMRS 1166, Hôpital Pitié-Salpêtrière, Paris, France
| | - Olivier Varenne
- Université de Paris, Paris, France,Department of Cardiology, Hôpital Cochin AP-HP, Paris, France
| | - Laurent Bonello
- Mediterranean Association for research and studies in cardiology (MARS CARDIO) and Centre for cardiovascular and nutrition research, INSERM 1263, INRA 1260, Marseille, France,Cardiology Department, Hôpital Nord, Marseille, France
| | - Pierre Coste
- Intensive Cardiology Care Unit and Interventional Cardiology, Hôpital Cardiologique du Haut-Lévêque, Pessac, France
| | - Nicolas Delarche
- Department of Cardiology, Centre Hospitalier de Pau, Pau, France
| | - Jean-Louis Georges
- Cardiology Department, Centre Hospitalier de Versailles, Le Chesnay-Rocquencourt, France
| | | | - Vincent Letocart
- Department of Cardiology, Thorax Institute, Nantes University Hospital, Nantes, France
| | - Gilles Chatellier
- Clinical Research Unit and CIC 1418 INSERM, Hôpital Européen Georges Pompidou AP-HP, Paris, France
| | - Nicolas Danchin
- Department of Cardiology, Hôpital Européen Georges Pompidou AP-HP, Paris, France,Université de Paris, Paris, France,French Alliance for Cardiovascular Trials (FACT), Paris, France
| | - Isabelle Durand-Zaleski
- Clinical Research Unit Eco Ile de France, Hôpital Hôtel Dieu AP-HP, Paris, France,Université de Paris Est Creteil (UPEC), Créteil, France
| |
Collapse
|
13
|
Georges JL, Cheggour S. [Telemedicine, remote medicine, e-health : are French cardiologists ready ?]. Ann Cardiol Angeiol (Paris) 2021; 70:267-268. [PMID: 34635332 DOI: 10.1016/j.ancard.2021.09.015] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/10/2021] [Accepted: 09/13/2021] [Indexed: 11/18/2022]
Affiliation(s)
- Jean-Louis Georges
- Service de cardiologie, Centre Hospitalier de Versailles, 78150 Le Chesnay-Rocquencourt, France ; rédacteur associé CNCH des Annales de Cardiologie et Angéiologie.
| | - Saida Cheggour
- Service de cardiologie, Centre Hospitalier d'Avignon, 84000 AVIGNON, France ; membre du conseil d'administration de la Société Française de Santé Digitale (SFSD).
| |
Collapse
|
14
|
Kerneis M, Cosentino F, Ferrari R, Georges JL, Kosmachova E, Laroche C, Maggioni AP, Rittger H, Steg PG, Szwed H, Tavazzi L, Valgimigli M, Gale CP, Komajda M. Impact of chronic coronary syndromes on cardiovascular hospitalization and mortality: the ESC-EORP CICD-LT registry. Eur Heart J 2021. [DOI: 10.1093/eurheartj/ehab724.1150] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/15/2022] Open
Abstract
Abstract
Background
In Europe, global data on guideline adherence, potential geographic variations and determinants of major clinical events in chronic coronary syndromes (CCS) remain suboptimal. The European Society of Cardiology (ESC) EURObservational Research Programme (EORP) Chronic Ischemic Cardiovascular Disease Long-Term (CICD-LT) registry, a prospective European registry, was designed and conducted to describe the profile, care and outcomes of patients with CCS across the ESC countries
Purpose
We aimed to investigate clinical events at one-year follow-up from the ESC EORP CICD-LT Registry and identify the variables associated with an increased risk of clinical events.
Methods
Consecutive adults presenting with a diagnosis of CCS during a routine ambulatory visit or an elective coronary revascularisation procedure at participating centres were recruited across 154 centers from 20 countries between 1 May 2015 and 31 July 2018. Information on clinical and survival status was collected after 1 year from study inclusion. Composite events were cardio-vascular (CV) mortality and/or CV rehospitalisations, all-cause mortality and/or all cause rehospitalisation. A multivariable Cox regression analysis was performed to identify the independent predictors of each composite. Cox models were also performed with age, sex and region forced in the model. Significance levels of 0.05 were required to allow a variable to stay within the model. Co-linearity between all candidate variables (variables with p<0.05 in univariable) within the model and variables considered of relevant clinical interest were tested before proceeding to the multivariable model. Missing data were not imputed.
Results
One-year outcomes of 6655 patients from the 9174 recruited in this European registry were analyzed. Overall, 168 patients (2.5%) died, mostly from CV causes (n=97, 1.5%). Northern Europe had the lowest CV mortality rate, while southern Europe had the highest (0.5% vs 2.0%, p=0.04). Women had a higher rate of CV mortality compared with men (2.0% vs 1.3%, p=0.02). During follow-up, 1606 patients (27.1%) were hospitalised at least once, predominantly for CV indications (n=1220, 20.6%). Among the population with measured LDL-cholesterol level at one year, 1434 patients (66.5%) were above the currently recommended target. Age, history of atrial fibrillation, previous stroke, liver disease, chronic obstructive pulmonary disease or asthma, increased serum creatinine and impaired left ventricular function were each independently associated with an increased risk of CV death or hospitalization.
Conclusion
In the CICD registry, the majority of patients with CCS have uncontrolled CV risk factors. The mortality rate at one year was low, but these patients are frequently hospitalised for CV causes. Early identification of comorbidities may represent an opportunity for enhanced care and better outcomes.
Funding Acknowledgement
Type of funding sources: Other. Main funding source(s): The study was funded by the EORP program.
Collapse
Affiliation(s)
- M Kerneis
- Pitié-Salpêtrière APHP University Hospital, ACTION Group, Department of Cardiology, Paris, France
| | - F Cosentino
- Karolinska University Hospital, Cardiology, Stockholm, Sweden
| | - R Ferrari
- University Hospital of Ferrara, Cardiology, Ferrara, Italy
| | - J L Georges
- Versailles Hospital, Cardiology, Versailles, France
| | - E Kosmachova
- Cuban Regional Clinical Hospital No 1, Scientific Research Clinical hospital, Krasnodar, Russian Federation
| | - C Laroche
- European Society of Cardiology, EURObservational Research Programme, Sophia-Antipolis, France
| | - A P Maggioni
- Maria Cecilia Hospital, GVM Care & Research, Cotignola, Italy
| | - H Rittger
- Clinic Fürth, Medizinische Klinik 1, Fuerth, Germany
| | - P G Steg
- Bichat Hospital, University Paris-Diderot, INSERM-UMR1148, FACT French Alliance for Cardiovascular T, Cardiology, Paris, France
| | - H Szwed
- National Institute of Cardiology, Warsaw, Poland
| | - L Tavazzi
- Maria Cecilia Hospital, GVM Care & Research, Cotignola, Italy
| | | | - C P Gale
- University of Leeds, Leeds Institute for Cardiovascular and Metabolic Medicine, Leeds, United Kingdom
| | - M Komajda
- Saint Joseph Hospital, Cardiology, Paris, France
| | | |
Collapse
|
15
|
Bensaid R, Georges JL, Angoulvant D, Chassaing S, Deballon R, Marcollet P, Albert F, Fichaux O, Bar O, Rangé G. INCREASED EXPOSURE TO X-RAYS DURING CORONARY ANGIOGRAPHY AND PERCUTANEOUS CORONARY INTERVENTIONS ASSOCIATED WITH FRACTIONAL FLOW RESERVE MEASUREMENT AND ENDOCORONARY IMAGING TECHNIQUES. Radiat Prot Dosimetry 2021; 194:18-26. [PMID: 33954788 DOI: 10.1093/rpd/ncab065] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 11/09/2020] [Revised: 03/09/2021] [Accepted: 04/08/2021] [Indexed: 06/12/2023]
Abstract
Growing use of fractional flow reserve (FFR) and intracoronary imaging techniques by optical coherence tomography or intravascular ultrasound has raised concerns about additional exposure during coronary angiography and percutaneous coronary interventions (PCIs). Using data from the prospective CRAC-France PCI Prospective Multicentre registry, we sought to evaluate the effect of these new techniques on the radiation dose to patients undergoing coronary procedures. Data on Kerma Area Product (PKA), total air kerma (KAr) and fluoroscopy time from 42 182 coronary procedures were retrospectively compared, using multivariable linear regression, according to whether they included FFR and intracoronary imaging. In coronary angiography, FFR was associated with longer fluoroscopy time and higher PKA (21.0 vs. 18.9 Gy.cm2) and KAr (372 vs. 299 mGy) (all p < 0.001). Intracoronary imaging was associated with longer fluoroscopy time, higher contrast volume (both p < 0.001), lower PKA (18.3 vs. 19.0 Gy.cm2, p = 0.02) and similar KAr. In PCI, FFR was associated with a moderate increase in KAr (682 vs. 626 mGy, p < 0.01) but not PKA (35.9 vs. 33.7 Gy.cm2, p = 0.34). For intracoronary imaging, there were no differences between groups, except for contrast volume. Increased patient exposure associated with FFR and intracoronary imaging is moderate in diagnostic coronary angiography and minimal or none in PCI, provided optimization techniques are used. It should not be a limitation on the use of these techniques given the important additional information they provide.
Collapse
Affiliation(s)
- Réda Bensaid
- Cardiology Department, Les Hôpitaux de Chartres, 28630 Le Coudray, France
| | - Jean-Louis Georges
- Cardiology Department, Centre Hospitalier de Versailles, 78150 Le Chesnay-Rocquencourt, France
| | - Denis Angoulvant
- Cardiology Department, Centre Hospitalo-Universitaire de Tours, and Tours University, 37000 Tours, France
| | - Stephan Chassaing
- Cardiology Department, Centre Hospitalier Régional d'Orléans, 45100 Orléans, France
| | - Ronan Deballon
- Cardiology Department, Clinique Oréliance, 45770 Saran, France
| | - Pierre Marcollet
- Cardiology Department, Centre Hospitalier de Bourges, 18000 Bourges, France
| | - Franck Albert
- Cardiology Department, Les Hôpitaux de Chartres, 28630 Le Coudray, France
| | - Olivier Fichaux
- Cardiology Department, Centre Hospitalier Régional d'Orléans, 45100 Orléans, France
| | - Olivier Bar
- Cardiology Department, Nouvelle clinique Tourengelle, 37000 Tours, France
| | - Grégoire Rangé
- Cardiology Department, Les Hôpitaux de Chartres, 28630 Le Coudray, France
| |
Collapse
|
16
|
Groh M, Pineton de Chambrun M, Georges JL, Panel K, Lefèvre G, Kahn JE, Tcherakian C, Convers-Domart R. Recurrent cardiac arrest due to eosinophilia-related coronary vasospasm successfully treated by benralizumab. J Allergy Clin Immunol Pract 2021; 9:3497-3499.e1. [PMID: 34020050 DOI: 10.1016/j.jaip.2021.04.067] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Subscribe] [Scholar Register] [Received: 03/23/2021] [Revised: 04/28/2021] [Accepted: 04/28/2021] [Indexed: 11/17/2022]
Affiliation(s)
- Matthieu Groh
- National Reference Center for Hypereosinophilic Syndromes (CEREO), France; Department of Internal Medicine, Hôpital Foch, Suresnes, France.
| | - Marc Pineton de Chambrun
- Sorbonne Université, Assistance Publique-Hôpitaux de Paris (APHP), Hôpital La Pitié-Salpêtrière, Service de Médecine Intensive-Réanimation, Paris, France; Sorbonne Université, APHP, Hôpital La Pitié-Salpêtrière, Institut E3M, Service de Médecine Interne 2; Centre de Référence National Lupus Systémique, Syndrome des Anticorps Anti-phospholipides et Autres Maladies Auto-Immunes Systémiques Rares, Paris, France; Sorbonne Université, INSERM, UMRS_1166-ICAN, Institut de Cardiométabolisme et Nutrition (ICAN), Paris, France
| | - Jean-Louis Georges
- Department of Cardiology, Centre Hospitalier de Versailles, Le Chesnay-Rocquencourt, France
| | - Kewin Panel
- National Reference Center for Hypereosinophilic Syndromes (CEREO), France; Clinical Research Department, Hôpital Foch, Suresnes, France
| | - Guillaume Lefèvre
- National Reference Center for Hypereosinophilic Syndromes (CEREO), France; Université de Lille, CHU Lille, Institut d'Immunologie, Lille, France
| | - Jean-Emmanuel Kahn
- National Reference Center for Hypereosinophilic Syndromes (CEREO), France; Université Paris Saclay, Department of Internal Medicine, Hôpital Ambroise Paré, Boulogne-Billancourt, France
| | - Colas Tcherakian
- National Reference Center for Hypereosinophilic Syndromes (CEREO), France; Department of Respiratory Medicine, Hôpital Foch, Suresnes, France
| | | |
Collapse
|
17
|
Nicot F, Charbonnel C, Jego C, Jourda F, Vinsonneau U, Garçon P, Turlotte G, Rivière JF, Maurin M, Lubret R, Meimoun P, Akret C, Cournot M, Sokic C, Michel L, Lescure M, Kenizou D, Melay M, Fayard M, Chauvat A, Fouché R, Cartigny G, Dijoux N, Martin AC, Tho-Agostini A, Mann H, Magnin D, Goralski M, Pico F, Georges JL, Belle L. Use of ADAM-C and CHA2DS2-VASc scores to predict complex aortic atheroma after brain ischemia: A prospective observational study. Echocardiography 2021; 38:612-622. [PMID: 33764608 DOI: 10.1111/echo.15034] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/10/2020] [Revised: 02/03/2021] [Accepted: 03/01/2021] [Indexed: 11/29/2022] Open
Abstract
BACKGROUND AND AIMS Complex aortic atheroma (CAA) is a common cause of acute brain ischemia (BI), including ischemic stroke (IS) and transient ischemic attack (TIA), and is associated with recurrence. The CHA2DS2-VASc score is a useful tool for predicting stroke in patients with atrial fibrillation (AF), and can also predict cardiovascular events in other populations, including non-AF populations. The ADAM-C score is a new risk score for predicting the diagnostic yield of transesophageal echocardiography (TEE) after BI. We aimed to evaluate the ability of CHA2DS2-VASc and ADAM-C scores to predict CAA after BI. METHODS This prospective, multicenter, observational study included 1479 patients aged over 18 years who were hospitalized for BI. CAA was defined as the presence of one or more of the following criteria: thrombus, ulcerated plaque, or plaque thickening ≥ 4 mm. RESULTS CAA was diagnosed in 216 patients (14.6%). CHA2DS2-VASc and ADAM-C scores were significantly higher in the CAA group versus the non-CAA group (P < .0001 for both). The CHA2DS2-VASc and ADAM-C scores appear to be good predictors of CAA (AUC 0.699 [0.635, 0.761] and 0.759 [0.702, 0.814], respectively). The sensitivity, specificity, predictive positive value (PPV), and negative predictive value (NPV) of the scores for detecting CAA were 94%, 22%, 17%, and 96%, respectively, for a CHA2DS2-VASc score < 2, and 90%, 46%, 22%, and 96%, respectively, for an ADAM-C score < 3 CONCLUSIONS: CHA2DS2-VASc and ADAM-C scores are able to predict CAA after BI. CHA2DS2-VASc < 2 and ADAM-C < 3 both have an interesting NPV of 96%.
Collapse
Affiliation(s)
- Florence Nicot
- Department of Cardiology, Versailles Hospital, Le Chesnay, France
| | | | - Christophe Jego
- Department of Cardiology, Toulon inter-armée Hospital, Toulon, France
| | | | - Ulric Vinsonneau
- Department of Cardiology, Brest inter-armée Hospital, Brest, France
| | - Philippe Garçon
- Department of Cardiology, Saint Joseph Hospital, Paris, France
| | - Guillaume Turlotte
- Department of Cardiology, La Roche sur Yon Hospital, La Roche sur Yon, France
| | | | - Marion Maurin
- Department of Cardiology, CHU Grenoble-Alpes, Grenoble, France
| | - Rémy Lubret
- Department of Cardiology, Boulogne sur mer Hospital, Boulogne sur mer, France
| | - Patrick Meimoun
- Department of Cardiology, Compiègne Hospital, Compiègne, France
| | - Chrystelle Akret
- Department of Cardiology, Annecy-Genevois Hospital, Annecy, France
| | - Maxime Cournot
- Department of Cardiology, Saint Paul Hospital, Saint Paul, France
| | - Charles Sokic
- Department of Cardiology, Haguenau Hospital, Haguenau, France
| | - Laurent Michel
- Department of Cardiology, Saint Lo Hospital, Saint Lo, France
| | | | - David Kenizou
- Department of Cardiology, Mulhouse Hospital, Mulhouse, France
| | - Marie Melay
- Department of Cardiology, Vichy Hospital, Vichy, France
| | - Maxime Fayard
- Department of Cardiology, Chalon sur Saone Hospital, Chalon sur Saone, France
| | - Anthony Chauvat
- Department of Cardiology, Argenteuil Hospital, Argenteuil, France
| | - Renaud Fouché
- Department of Cardiology, Montbéliard Hospital, Montbéliard, France
| | | | - Nicolas Dijoux
- Department of Cardiology, Saint Pierre Hospital, Saint Pierre, France
| | - Anne Céline Martin
- Department of Cardiology, European Georges Pompidou Hospital, Paris, France
| | | | - Hubert Mann
- Department of Cardiology, Voiron Hospital, Voiron, France
| | | | - Marc Goralski
- Department of Cardiology, Orléans Hospital, Orléans, France
| | - Fernando Pico
- Department of Cardiology, Versailles Hospital, Le Chesnay, France.,Department of Neurology, Université Versailles Saint-Quentin en Yvelines et Paris Saclay, Le Chesnay, France
| | | | - Loïc Belle
- Department of Cardiology, Annecy-Genevois Hospital, Annecy, France
| |
Collapse
|
18
|
Silvain J, Cayla G, Beygui F, Range G, Lattuca B, Collet JP, Dillinger JG, Boueri Z, Brunel P, Pouillot C, Boccara F, Christiaens L, Labeque JN, Lhermusier T, Georges JL, Bellemain-Appaix A, Le Breton H, Hauguel-Moreau M, Saint-Etienne C, Caussin C, Jourda F, Motovska Z, Guedeney P, El Kasty M, Laredo M, Dumaine R, Ducrocq G, Vicaut E, Montalescot G. Blunting periprocedural myocardial necrosis: Rationale and design of the randomized ALPHEUS study. Am Heart J 2020; 225:27-37. [PMID: 32473356 DOI: 10.1016/j.ahj.2020.04.017] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 03/01/2020] [Accepted: 04/23/2020] [Indexed: 02/01/2023]
Abstract
BACKGROUND Clopidogrel associated with aspirin is the recommended treatment for patients undergoing elective percutaneous coronary intervention (PCI). Although severe PCI-related events are rare, evidence suggests that PCI-related myocardial infarction and myocardial injury are frequent complications that can impact the clinical prognosis of the patients. Antiplatelet therapy with a potent P2Y12 receptor inhibitor such as ticagrelor may reduce periprocedural ischemic complications while maintaining a similar safety profile as compared with conventional dual antiplatelet therapy by aspirin and clopidogrel in this setting. METHODS Assessment of Loading with the P2Y12 inhibitor ticagrelor or clopidogrel to Halt ischemic Events in patients Undergoing elective coronary Stenting (ALPHEUS) (NCT02617290) is an international, multicenter, randomized, parallel-group, open-label study in patients with stable coronary artery disease who are planned for an elective PCI. In total, 1,900 patients will be randomized before a planned PCI to a loading dose of ticagrelor 180 mg or a loading dose of clopidogrel (300 or 600 mg) in addition to aspirin. Patients will then receive a dual antiplatelet therapy with aspirin and ticagrelor 90 mg twice daily or clopidogrel 75 mg once daily for 30 days. The primary ischemic end point is PCI-related myocardial infarction (myocardial infarction type 4a or 4b) or major myocardial injury within 48 hours (or at hospital discharge if earlier) after elective PCI/stent. Safety will be evaluated by major bleeding events (Bleeding Academic Research Consortium type 3 or 5) at 48 hours (or discharge if it occurs earlier). CONCLUSION ALPHEUS is the first properly sized trial comparing ticagrelor to clopidogrel in the setting of elective PCI and is especially designed to show a reduction in periprocedural events, a surrogate end point for mortality.
Collapse
Affiliation(s)
- Johanne Silvain
- Sorbonne Université, ACTION Study Group, INSERM UMRS1166, Hôpital Pitié-Salpêtrière (AP-HP), Paris, France
| | - Guillaume Cayla
- Cardiology department, Nîmes university Hospital, Montpellier University, ACTION study group, Nîmes, France
| | - Farzin Beygui
- CHU de Caen-Département de Cardiologie; Caen, France
| | - Grégoire Range
- CH de Chartres-Département de Cardiologie, Chartes, France
| | - Benoit Lattuca
- Cardiology department, Nîmes university Hospital, Montpellier University, ACTION study group, Nîmes, France
| | - Jean-Philippe Collet
- Sorbonne Université, ACTION Study Group, INSERM UMRS1166, Hôpital Pitié-Salpêtrière (AP-HP), Paris, France
| | - Jean-Guillaume Dillinger
- Department of Cardiology, Inserm U942, Lariboisière Hospital, Assistance Publique-Hôpitaux de Paris, University of Paris, Paris, France
| | - Ziad Boueri
- CH de Bastia-Département de Cardiologie, Bastia, France
| | - Philippe Brunel
- Hôpital Privé Dijon Bourgogne-Cardiologie Interventionelle GCIDB VALMY, Dijon, France
| | - Christophe Pouillot
- Clinique Sainte Clotilde, La Réunion-Département de Cardiologie, La Réunion, France
| | - Franck Boccara
- AP-HP, Hôpitaux de l'Est Parisien, Hôpital Saint-Antoine, Department of Cardiology, Sorbonne Université-INSERM UMR S_938, Centre de Recherche Saint-Antoine, Paris, France
| | | | | | | | - Jean-Louis Georges
- CH de Versailles-Service de Cardiologie, Hôpital A. Mignot, Le Chesnay, France
| | - Anne Bellemain-Appaix
- CH d'Antibes Juan-Les-Pins-Département de Cardiologie, Antibes Juan-Les-Pins, France
| | | | - Marie Hauguel-Moreau
- CHU Ambroise Paré (APHP), Université Versailles-Saint Quentin, ACTION study Group, INSERM-U1018 CESP, Boulogne, France-Service de Cardiologie
| | | | - Christophe Caussin
- Institut Mutualiste Montsouris-Département de Cardiologie, Paris, France
| | | | - Zuzana Motovska
- 3rd Faculty of Medicine, Charles University and Cardiocentre Kralovske Vinohrady, Prague, Czech Republic
| | - Paul Guedeney
- Sorbonne Université, ACTION Study Group, INSERM UMRS1166, Hôpital Pitié-Salpêtrière (AP-HP), Paris, France
| | - Mohamad El Kasty
- Grand Hôpital de l'Est Francilien site Marne-La-Vallée - Département de Cardiologie, Marne La Vallée, France
| | - Mikael Laredo
- Sorbonne Université, ACTION Study Group, INSERM UMRS1166, Hôpital Pitié-Salpêtrière (AP-HP), Paris, France
| | - Raphaëlle Dumaine
- Les Grands Prés Cardiac Rehabilitation center, Villeneuve St Denis, France
| | - Grégory Ducrocq
- FACT (French Alliance for Cardiovascular Trials), DHU FIRE, Hôpital Bichat, AP-HP, Université de Paris, Inserm U-1148, Paris, France
| | - Eric Vicaut
- Unité de Recherche Clinique, ACTION Study Group, Hôpital Fernand Widal (AP-HP), Paris, France; SAMM - Statistique, Analyse et Modélisation Multidisciplinaire EA 4543, Université Paris 1 Panthéon Sorbonne, Paris, France
| | - Gilles Montalescot
- Sorbonne Université, ACTION Study Group, INSERM UMRS1166, Hôpital Pitié-Salpêtrière (AP-HP), Paris, France.
| |
Collapse
|
19
|
Huet C, Entine F, Bassinet C, Dondey M, Dreuil S, Georges JL, Etard C, Clairand I. SESAME: A TOOL FOR NUMERICAL DOSIMETRIC RECONSTRUCTION OF PATIENTS OVEREXPOSURES IN INTERVENTIONAL RADIOLOGY. Radiat Prot Dosimetry 2019; 185:231-238. [PMID: 30753615 DOI: 10.1093/rpd/ncz004] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 07/23/2018] [Revised: 11/27/2018] [Accepted: 01/14/2019] [Indexed: 06/09/2023]
Abstract
Radiation overexposure accidents are rare but can have severe health consequences. Evaluating the dose received by the patient is a crucial step in the medical management. For that purpose, for more than 15 years, IRSN has been developing an in-house tool named SESAME for the numerical reconstruction of radiological accidents due to external sources. Recently, two new functionalities were implemented in SESAME to allow accurate reconstructions of interventional radiology (IR) overexposures. The experimental validation of SESAME for the reconstruction of overexposures in IR is presented. First, an anthropomorphic dummy equipped with dosemeters was irradiated following conditions similar to a fluoroscopically guided interventional procedure. Then the procedure was simulated using SESAME. Finally measured doses were compared to calculated doses. Even with a limited amount of data available, SESAME can provide valuable dose information for the medical team in charge of the patient, such as skin dose mapping and dose distribution in depth.
Collapse
Affiliation(s)
- Christelle Huet
- Institut de Radioprotection et de Sûreté Nucléaire (IRSN), Pôle Santé et Environnement, 31 Avenue de la Division Leclerc, 92260 Fontenay-aux- Roses, France
| | - Fabrice Entine
- Institut de Radioprotection et de Sûreté Nucléaire (IRSN), Pôle Santé et Environnement, 31 Avenue de la Division Leclerc, 92260 Fontenay-aux- Roses, France
| | - Céline Bassinet
- Institut de Radioprotection et de Sûreté Nucléaire (IRSN), Pôle Santé et Environnement, 31 Avenue de la Division Leclerc, 92260 Fontenay-aux- Roses, France
| | - Matthieu Dondey
- Institut de Radioprotection et de Sûreté Nucléaire (IRSN), Pôle Santé et Environnement, 31 Avenue de la Division Leclerc, 92260 Fontenay-aux- Roses, France
| | - Serge Dreuil
- Institut de Radioprotection et de Sûreté Nucléaire (IRSN), Pôle Santé et Environnement, 31 Avenue de la Division Leclerc, 92260 Fontenay-aux- Roses, France
| | - Jean-Louis Georges
- Service de Cardiologie, Centre Hospitalier de Versailles André Mignot, 177 rue de Versailles, 78150 Le Chesnay, France
| | - Cécile Etard
- Institut de Radioprotection et de Sûreté Nucléaire (IRSN), Pôle Santé et Environnement, 31 Avenue de la Division Leclerc, 92260 Fontenay-aux- Roses, France
| | - Isabelle Clairand
- Institut de Radioprotection et de Sûreté Nucléaire (IRSN), Pôle Santé et Environnement, 31 Avenue de la Division Leclerc, 92260 Fontenay-aux- Roses, France
| |
Collapse
|
20
|
Cherif G, Georges JL, Convers R, De Malherbe M, Ajlani B, Dagher Hayeck Y, Larnier L, Blicq E, Charbonnel C, Legriel S, Hervé D, Livarek B. [Coronary artery spasm revealed by an out-of-hospital cardiac arrest associated with a moyamoya disease. A case report of multimodality imaging]. Ann Cardiol Angeiol (Paris) 2019; 68:375-381. [PMID: 31471042 DOI: 10.1016/j.ancard.2019.07.013] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/10/2019] [Accepted: 07/19/2019] [Indexed: 06/10/2023]
Abstract
Moyamoya disease is a rare angiopathy characterized by a progressive distal occlusion of the internal carotid arteries and their branches. Extracerebral involvement, including coronary arteries, has been described. We report the case of a patient with moyamoya disease who suffered an out-of-hospital cardiac arrest associated with coronary spasm. We discussed the possible links between coronary spasm and moyamoya, as well as the contribution of multimodal cardiac imaging, combining conventional and intracoronary imaging, cardiac MRI, provocative tests for spasm, in the exploration of out-of-hospital cardiac arrest without obvious electrocardiographic and angiographic cause.
Collapse
Affiliation(s)
- G Cherif
- Service de cardiologie, hôpital André-Mignot, centre hospitalier de Versailles, 177, rue de Versailles, 78150 Le Chesnay, France
| | - J L Georges
- Service de cardiologie, hôpital André-Mignot, centre hospitalier de Versailles, 177, rue de Versailles, 78150 Le Chesnay, France.
| | - R Convers
- Service de cardiologie, hôpital André-Mignot, centre hospitalier de Versailles, 177, rue de Versailles, 78150 Le Chesnay, France
| | - M De Malherbe
- Service de radiologie, hôpital André-Mignot, centre hospitalier de Versailles, 78150 Le Chesnay, France
| | - B Ajlani
- Service de cardiologie, hôpital André-Mignot, centre hospitalier de Versailles, 177, rue de Versailles, 78150 Le Chesnay, France
| | - Y Dagher Hayeck
- Service de cardiologie, hôpital André-Mignot, centre hospitalier de Versailles, 177, rue de Versailles, 78150 Le Chesnay, France; Service de rythmologie, institut de cardiologie, hôpital universitaire de la Pitié-Salpétrière, Assistance publique-Hôpitaux de Paris, 75013 Paris, France
| | - L Larnier
- Service de cardiologie, hôpital André-Mignot, centre hospitalier de Versailles, 177, rue de Versailles, 78150 Le Chesnay, France; Service de rythmologie, institut de cardiologie, hôpital universitaire de la Pitié-Salpétrière, Assistance publique-Hôpitaux de Paris, 75013 Paris, France
| | - E Blicq
- Service de cardiologie, hôpital André-Mignot, centre hospitalier de Versailles, 177, rue de Versailles, 78150 Le Chesnay, France
| | - C Charbonnel
- Service de cardiologie, hôpital André-Mignot, centre hospitalier de Versailles, 177, rue de Versailles, 78150 Le Chesnay, France
| | - S Legriel
- Service de réanimation médicale, hôpital André-Mignot, centre hospitalier de Versailles, 78150 Le Chesnay, France
| | - D Hervé
- Service de neurologie, groupe hospitalier Saint-Louis-Lariboisière Fernand-Widal, Assistance publique-Hôpitaux de Paris, 78018 Paris, France
| | - B Livarek
- Service de cardiologie, hôpital André-Mignot, centre hospitalier de Versailles, 177, rue de Versailles, 78150 Le Chesnay, France
| |
Collapse
|
21
|
Pham V, Midey C, Georges JL, Lefevre G, Blicq E, Charbonnel C, Legriel S, Livarek B. [Isolated right ventricular acute myocardial infarction mimicking anterior infarction]. Ann Cardiol Angeiol (Paris) 2019; 68:389-393. [PMID: 31540702 DOI: 10.1016/j.ancard.2019.08.012] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/02/2019] [Accepted: 08/28/2019] [Indexed: 06/10/2023]
Abstract
Isolated right ventricular acute myocardial infarction is rare and its presentation can sometimes mimic an anterior ST-segment elevation myocardial infarction. We reported two cases of isolated right ventricular acute myocardial infarction presenting with a ST-elevation in anterior leads. The first case was admitted for an out-of-hospital cardiac arrest due to ventricular fibrillation. The patient died from neurologic consequences of the cardiac arrest, despite a successful prehospital thrombolysis, followed by a percutaneous angioplasty of the right coronary artery. The second case occurred after a complex percutaneous angioplasty of the right coronary artery, complicated by a total occlusion of a right marginal branch. These two cases illustrate the limits of the ECG for the diagnosis of isolated right ventricular acute infarction, and the difficulties of the differential diagnosis with anterior infarction, which may determine the treatment and the prognosis.
Collapse
Affiliation(s)
- V Pham
- Service de cardiologie, centre hospitalier de Versailles, hôpital André Mignot, 177 rue de Versailles, 78150 Le Chesnay, France
| | - C Midey
- Service de cardiologie, centre hospitalier de Versailles, hôpital André Mignot, 177 rue de Versailles, 78150 Le Chesnay, France
| | - J L Georges
- Service de cardiologie, centre hospitalier de Versailles, hôpital André Mignot, 177 rue de Versailles, 78150 Le Chesnay, France.
| | - G Lefevre
- Service de cardiologie, centre hospitalier de Versailles, hôpital André Mignot, 177 rue de Versailles, 78150 Le Chesnay, France
| | - E Blicq
- Service de cardiologie, centre hospitalier de Versailles, hôpital André Mignot, 177 rue de Versailles, 78150 Le Chesnay, France
| | - C Charbonnel
- Service de cardiologie, centre hospitalier de Versailles, hôpital André Mignot, 177 rue de Versailles, 78150 Le Chesnay, France
| | - S Legriel
- Service de réanimation médicale, Centre Hospitalier de Versailles, Hôpital André Mignot, 78150 Le Chesnay, France
| | - B Livarek
- Service de cardiologie, centre hospitalier de Versailles, hôpital André Mignot, 177 rue de Versailles, 78150 Le Chesnay, France
| |
Collapse
|
22
|
Dujardin JJ, Belle L, Yayehd K, Georges JL. [Takotsubo cardiomyopathy]. Rev Prat 2019; 69:877-880. [PMID: 32237653] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 06/11/2023]
Abstract
Takotsubo cardiomyopathy. Takotsubo cardiomyopathy, or transient apical ballooning syndrome of the left ventricle, affects women after menopause often after mental or physical stress. Mimicking clinical, electrocardiographic and biological features of an acute coronary syndrome, it requires admission to the intensive care unit and an immediate coronary angiography, which will show the absence of coronary occlusion or rupture of atheromatous plaque. Echocardiogram, left ventriculography if performed, and magnetic resonance imaging will confirm the left ventricular deformation and impairment of systolic function, and the absence of myocardial infarction. Evolution is usually towards recovery of ventricular deformation, and improvement of systolic function, but complications in the acute phase, and recurrences are possible. Treatment is not yet standardised and should include psychological care.
Collapse
Affiliation(s)
| | - Loïc Belle
- Service de cardiologie, centre hospitalier d'Annecy Genevois, Épagny Metz-Tessy, France
| | - Komlavi Yayehd
- Service de cardiologie, centre hospitalier universitaire, campus 03BP 30284, Lomé, Togo
| | - Jean-Louis Georges
- Service de cardiologie, centre hospitalier de Versailles, Le Chesnay, France
| |
Collapse
|
23
|
Mavrakanas TA, Chatzizisis YS, Gariani K, Kereiakes DJ, Gargiulo G, Helft G, Gilard M, Feres F, Costa RA, Morice MC, Georges JL, Valgimigli M, Bhatt DL, Mauri L, Charytan DM. Duration of Dual Antiplatelet Therapy in Patients with CKD and Drug-Eluting Stents: A Meta-Analysis. Clin J Am Soc Nephrol 2019; 14:810-822. [PMID: 31010936 PMCID: PMC6556713 DOI: 10.2215/cjn.12901018] [Citation(s) in RCA: 13] [Impact Index Per Article: 2.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/31/2018] [Accepted: 03/27/2019] [Indexed: 12/30/2022]
Abstract
BACKGROUND AND OBJECTIVES Whether prolonged dual antiplatelet therapy (DAPT) is more protective in patients with CKD and drug-eluting stents compared with shorter DAPT is uncertain. The purpose of this meta-analysis was to examine whether shorter DAPT in patients with drug-eluting stents and CKD is associated with lower mortality or major adverse cardiovascular event rates compared with longer DAPT. DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS A Medline literature research was conducted to identify randomized trials in patients with drug-eluting stents comparing different DAPT duration strategies. Inclusion of patients with CKD was also required. The primary outcome was a composite of all-cause mortality, myocardial infarction, stroke, or stent thrombosis (definite or probable). Major bleeding was the secondary outcome. The risk ratio (RR) was estimated using a random-effects model. RESULTS Five randomized trials were included (1902 patients with CKD). Short DAPT (≤6 months) was associated with a similar incidence of the primary outcome, compared with 12-month DAPT among patients with CKD (48 versus 50 events; RR, 0.93; 95% confidence interval [95% CI], 0.64 to 1.36; P=0.72). Twelve-month DAPT was also associated with a similar incidence of the primary outcome compared with extended DAPT (≥30 months) in the CKD subgroup (35 versus 35 events; RR, 1.04; 95% CI, 0.67 to 1.62; P=0.87). Numerically lower major bleeding event rates were detected with shorter versus 12-month DAPT (9 versus 13 events; RR, 0.69; 95% CI, 0.30 to 1.60; P=0.39) and 12-month versus extended DAPT (9 versus 12 events; RR, 0.83; 95% CI, 0.35 to 1.93; P=0.66) in patients with CKD. CONCLUSIONS Short DAPT does not appear to be inferior to longer DAPT in patients with CKD and drug-eluting stents. Because of imprecision in estimates (few events and wide confidence intervals), no definite conclusions can be drawn with respect to stent thrombosis.
Collapse
Affiliation(s)
- Thomas A Mavrakanas
- Renal Division, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts; .,Department of Medicine, Geneva University Hospitals, Geneva, Switzerland
| | | | - Karim Gariani
- Division of Diabetes and Endocrinology, Geneva University Hospitals and Faculty of Medicine, Geneva, Switzerland
| | - Dean J Kereiakes
- The Christ Hospital Heart and Vascular Center and The Lindner Center for Research and Education, Cincinnati, Ohio
| | - Giuseppe Gargiulo
- Department of Cardiology, Bern University Hospital, University of Bern, Bern, Switzerland.,Department of Advanced Biomedical Sciences, University Federico II of Naples, Naples, Italy
| | - Gérard Helft
- Institute of Cardiology, University Hospitals Pitié-Salpêtrière- Charles Foix (Public Assistance- Hospitals of Paris), Sorbonne University, Paris, France
| | - Martine Gilard
- Division of Cardiology, Regional University Hospital La Cavale Blanche, Brest, France
| | - Fausto Feres
- Institute Dante Pazzanese de Cardiologia, Sao Paulo, Sao Paulo, Brazil
| | - Ricardo A Costa
- Institute Dante Pazzanese de Cardiologia, Sao Paulo, Sao Paulo, Brazil
| | | | | | - Marco Valgimigli
- Department of Cardiology, Bern University Hospital, University of Bern, Bern, Switzerland
| | - Deepak L Bhatt
- Brigham and Women's Hospital Heart and Vascular Center, Harvard Medical School, Boston, Massachusetts
| | - Laura Mauri
- Division of Cardiovascular Medicine, Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts
| | - David M Charytan
- Renal Division, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts.,Baim Institute for Clinical Research, Boston, Massachusetts; and.,Division of Nephrology, New York University Langone Medical Center, New York, New York
| |
Collapse
|
24
|
Helft G, Steg PG, Georges JL, Cherifi S, Hage G, Zeitouni M, Hammoudi N, Diallo A, Berman E, Silvain J, Metzger JPH, Le Feuvre C. 6132The OPTIDUAL trial: long term follow-up. Eur Heart J 2018. [DOI: 10.1093/eurheartj/ehy566.6132] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
Affiliation(s)
- G Helft
- Institut de Cardiologie, Paris, France
| | | | | | - S Cherifi
- Institut de Cardiologie, Paris, France
| | - G Hage
- Institut de Cardiologie, Paris, France
| | | | | | - A Diallo
- Hospital Lariboisiere, URC Lariboisiere, Paris, France
| | - E Berman
- Institut de Cardiologie, Paris, France
| | - J Silvain
- Institut de Cardiologie, Paris, France
| | | | | | | |
Collapse
|
25
|
Charbonnel C, Convers-Domart R, Rigaudeau S, Taksin AL, Baron N, Lambert J, Ghez S, Georges JL, Farhat H, Lambert J, Rousselot P, Livarek B. Assessment of global longitudinal strain at low-dose anthracycline-based chemotherapy, for the prediction of subsequent cardiotoxicity. Eur Heart J Cardiovasc Imaging 2018; 18:392-401. [PMID: 28064155 DOI: 10.1093/ehjci/jew223] [Citation(s) in RCA: 33] [Impact Index Per Article: 5.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 06/16/2016] [Accepted: 09/25/2016] [Indexed: 01/30/2023] Open
Abstract
Aims We sought to assess whether global longitudinal strain (GLS) measured early during treatment with anthracyclines (at a cumulative dose of 150 mg/m2) can predict subsequent alterations in left ventricular ejection fraction. Methods and results Eighty-six patients with Hodgkin's disease, non-Hodgkin's lymphoma, or acute leukaemia and receiving anthracyclines were prospectively included. Patients underwent complete echocardiography on four occasions: baseline (V1); after reaching a cumulative dose of 150 mg/m2 (V2); end of treatment (V3); and 1 year follow-up (V4). Six patients developed cardiotoxicity, defined as a decrease in left ventricular ejection fraction of >10 percentage points, to a value <53%, at V4. GLS measured at V1 and V2 was significantly lower in the cardiotoxicity group vs. the controls (P = 0.042 and P = 0.01, respectively). Compared with GLS at V1, GLS obtained at V2 provided incremental predictive information and appeared to be the strongest predictor of cardiotoxicity (area under the receiver-operating-characteristic curve, 0.82). At a threshold of -17.45% for GLS measured at V2, the sensitivity and specificity of detecting cardiotoxicity were 67% (95% confidence interval 33-100) and 97% (95% confidence interval 94-100), respectively. Conclusion GLS greater than -17.45%, obtained after 150 mg/m2 of anthracycline therapy, is an independent predictor of future anthracycline-induced cardiotoxicity. These findings should encourage physicians to perform echocardiography earlier during treatment with anthracyclines.
Collapse
Affiliation(s)
- Clément Charbonnel
- Department of Cardiology, Versailles Hospital, 177 rue de Versailles, 78150 Le Chesnay, France
| | - Raphaele Convers-Domart
- Department of Cardiology, Versailles Hospital, 177 rue de Versailles, 78150 Le Chesnay, France
| | - Sophie Rigaudeau
- Department of Hematology, Versailles Hospital, 177 rue de Versailles, 78150 Le Chesnay, France
| | - Anne Laure Taksin
- Department of Hematology, Versailles Hospital, 177 rue de Versailles, 78150 Le Chesnay, France
| | - Nicolas Baron
- Department of Cardiology, Versailles Hospital, 177 rue de Versailles, 78150 Le Chesnay, France
| | - Juliette Lambert
- Department of Hematology, Versailles Hospital, 177 rue de Versailles, 78150 Le Chesnay, France
| | - Stéphanie Ghez
- Department of Hematology, Versailles Hospital, 177 rue de Versailles, 78150 Le Chesnay, France
| | - Jean-Louis Georges
- Department of Cardiology, Versailles Hospital, 177 rue de Versailles, 78150 Le Chesnay, France
| | - Hassan Farhat
- Department of Hematology, Versailles Hospital, 177 rue de Versailles, 78150 Le Chesnay, France
| | - Jérôme Lambert
- Department of Biostatistics, Saint Louis Hospital, 1 Avenue Claude Vellefaux, 75010 Paris, France
| | - Philippe Rousselot
- Department of Hematology, Versailles Hospital, 177 rue de Versailles, 78150 Le Chesnay, France
| | - Bernard Livarek
- Department of Cardiology, Versailles Hospital, 177 rue de Versailles, 78150 Le Chesnay, France
| |
Collapse
|
26
|
Pichard S, Gibault-Genty G, Vienet-Legue A, Baron N, Convers-Domart R, Georges JL, Livarek B. [Complicated transcatheter aortic-valve endocarditis with abscess and pseudoaneurysm: Value of the ECG-gated multidetector computed tomography angiography]. Ann Cardiol Angeiol (Paris) 2017; 66:338-342. [PMID: 29050736 DOI: 10.1016/j.ancard.2017.09.007] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/15/2017] [Accepted: 09/12/2017] [Indexed: 06/07/2023]
Abstract
A 80-year-old man was admitted to catheterization room for an acute infero-lateral ST-elevation myocardial infarction (STEMI). Coronary angiography showed a thrombotic occlusion of the second left marginal branch, and normal other coronary arteries. The thrombo-embolic mechanism of the STEMI, and the infectious context in this patient who had had a transcatheter aortic valve implantation (TAVI) two months earlier, led us to suspect a bioprosthesis endocarditis. It was confirmed by transthoracic and transoesophageal echocardiography, which showed an aortic-mitral curtain abscess and aortic bioprosthesis vegetations, associated to Enterococcus faecalis bacteriemia. In order to specify the diagnosis, an ECG-gated multidetector CT angiography (MDCTA) had been performed. Additionally to echocardiographic findings, MDCTA showed a pseudo-aneurysm, sized 20 to 22mm, beginning from the outflow tract of the left ventricle to end on the antero-lateral face of the aorta. The patient was referred for emergency aortic bioprosthesis removal and replacement. Through this case, MDCTA showed its importance for the diagnosis and the prognostic evaluation of cardiac prosthesis endocarditis. MDCTA provided additional informations that echocardiography could not detect, because of artifacts caused by the prosthetic material and calcifications, frequent in elderly patients with comorbidities.
Collapse
Affiliation(s)
- S Pichard
- Service de cardiologie, unité de soins intensif cardiologiques et cardiologie interventionnelle, hôpital Victor-Dupouy, centre hospitalier d'Argenteuil, 95100 Argenteuil, France
| | - G Gibault-Genty
- Service de cardiologie, unité de soins intensif cardiologiques et cardiologie interventionnelle, hôpital André-Mignot, centre hospitalier de Versailles, 177, rue de Versailles, 78150 Le-Chesnay, France.
| | - A Vienet-Legue
- Service de cardiologie, unité de soins intensif cardiologiques et cardiologie interventionnelle, hôpital André-Mignot, centre hospitalier de Versailles, 177, rue de Versailles, 78150 Le-Chesnay, France
| | - N Baron
- Service de cardiologie, unité de soins intensif cardiologiques et cardiologie interventionnelle, hôpital André-Mignot, centre hospitalier de Versailles, 177, rue de Versailles, 78150 Le-Chesnay, France
| | - R Convers-Domart
- Service de cardiologie, unité de soins intensif cardiologiques et cardiologie interventionnelle, hôpital André-Mignot, centre hospitalier de Versailles, 177, rue de Versailles, 78150 Le-Chesnay, France
| | - J L Georges
- Service de cardiologie, unité de soins intensif cardiologiques et cardiologie interventionnelle, hôpital André-Mignot, centre hospitalier de Versailles, 177, rue de Versailles, 78150 Le-Chesnay, France
| | - B Livarek
- Service de cardiologie, unité de soins intensif cardiologiques et cardiologie interventionnelle, hôpital André-Mignot, centre hospitalier de Versailles, 177, rue de Versailles, 78150 Le-Chesnay, France
| |
Collapse
|
27
|
Georges JL, Karam N, Tafflet M, Livarek B, Bataille S, Loyeau A, Mapouata M, Benamer H, Caussin C, Garot P, Varenne O, Barbou F, Teiger E, Funck F, Karrillon G, Lambert Y, Spaulding C, Jouven X. Time-Course Reduction in Patient Exposure to Radiation From Coronary Interventional Procedures. Circ Cardiovasc Interv 2017; 10:CIRCINTERVENTIONS.117.005268. [DOI: 10.1161/circinterventions.117.005268] [Citation(s) in RCA: 9] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 03/18/2017] [Accepted: 06/26/2017] [Indexed: 11/16/2022]
Abstract
Background—
The frequency of complex percutaneous coronary interventions (PCIs) has increased in the last few years, with a growing concern on the radiation dose received by the patients. Multicenter data from large unselected populations on patients’ radiation doses during coronary angiography (CA) and PCI and temporal trends are lacking. This study sought to evaluate the temporal trends in patients’ exposure to radiation from CA and PCI.
Methods and Results—
Data were taken from the CARDIO-ARSIF registry that prospectively collects data on all CAs and PCIs performed in the 36 catheterization laboratories in the Greater Paris Area, the most populated regions in France with about 12 million inhabitants. Kerma area product and Fluoroscopy time from 152 684 consecutive CAs and 103 177 PCIs performed between 2009 and 2013 were analyzed. A continuous trend for a decrease in median [interquartile range] Kerma area product was observed, from 33 [19–55] Gy cm
2
in 2009 to 27 [16–44] Gy cm
2
in 2013 for CA (
P
<0.0001), and from 73 [41–125] to 55 [31–91] Gy cm
2
for PCI (
P
<0.0001). Time-course differences in Kerma area product remained highly significant after adjustment on Fluoroscopy time, PCI procedure complexity, change of x-ray equipment, and other patient- and procedure-related covariates.
Conclusions—
In a large patient population, a steady temporal decrease in patient radiation exposure during CA and PCI was noted between 2009 and 2013. Kerma area product reduction was consistent in all types of procedure and was independent of patient-related factors and PCI procedure complexity.
Collapse
Affiliation(s)
- Jean-Louis Georges
- From the Cardiology Department (J.-L.G., B.L.), Emergency Department (S.B.), and SAMU 78 (Y.L.), Versailles Hospital (André Mignot), Le Chesnay, France; Paris Cardiovascular Research Center, INSERM Unit 970, France (N.K., M.T., C.S., X.J.); Cardiology Department, European Georges Pompidou University Hospital (N.K., C.S., X.J.), Cardiology Department, University Hospital Cochin (O.V.), and Cardiology Department, University Hospital Henri Mondor (E.T.), Assistance Publique-Hôpitaux de Paris, France
| | - Nicole Karam
- From the Cardiology Department (J.-L.G., B.L.), Emergency Department (S.B.), and SAMU 78 (Y.L.), Versailles Hospital (André Mignot), Le Chesnay, France; Paris Cardiovascular Research Center, INSERM Unit 970, France (N.K., M.T., C.S., X.J.); Cardiology Department, European Georges Pompidou University Hospital (N.K., C.S., X.J.), Cardiology Department, University Hospital Cochin (O.V.), and Cardiology Department, University Hospital Henri Mondor (E.T.), Assistance Publique-Hôpitaux de Paris, France
| | - Muriel Tafflet
- From the Cardiology Department (J.-L.G., B.L.), Emergency Department (S.B.), and SAMU 78 (Y.L.), Versailles Hospital (André Mignot), Le Chesnay, France; Paris Cardiovascular Research Center, INSERM Unit 970, France (N.K., M.T., C.S., X.J.); Cardiology Department, European Georges Pompidou University Hospital (N.K., C.S., X.J.), Cardiology Department, University Hospital Cochin (O.V.), and Cardiology Department, University Hospital Henri Mondor (E.T.), Assistance Publique-Hôpitaux de Paris, France
| | - Bernard Livarek
- From the Cardiology Department (J.-L.G., B.L.), Emergency Department (S.B.), and SAMU 78 (Y.L.), Versailles Hospital (André Mignot), Le Chesnay, France; Paris Cardiovascular Research Center, INSERM Unit 970, France (N.K., M.T., C.S., X.J.); Cardiology Department, European Georges Pompidou University Hospital (N.K., C.S., X.J.), Cardiology Department, University Hospital Cochin (O.V.), and Cardiology Department, University Hospital Henri Mondor (E.T.), Assistance Publique-Hôpitaux de Paris, France
| | - Sophie Bataille
- From the Cardiology Department (J.-L.G., B.L.), Emergency Department (S.B.), and SAMU 78 (Y.L.), Versailles Hospital (André Mignot), Le Chesnay, France; Paris Cardiovascular Research Center, INSERM Unit 970, France (N.K., M.T., C.S., X.J.); Cardiology Department, European Georges Pompidou University Hospital (N.K., C.S., X.J.), Cardiology Department, University Hospital Cochin (O.V.), and Cardiology Department, University Hospital Henri Mondor (E.T.), Assistance Publique-Hôpitaux de Paris, France
| | - Aurélie Loyeau
- From the Cardiology Department (J.-L.G., B.L.), Emergency Department (S.B.), and SAMU 78 (Y.L.), Versailles Hospital (André Mignot), Le Chesnay, France; Paris Cardiovascular Research Center, INSERM Unit 970, France (N.K., M.T., C.S., X.J.); Cardiology Department, European Georges Pompidou University Hospital (N.K., C.S., X.J.), Cardiology Department, University Hospital Cochin (O.V.), and Cardiology Department, University Hospital Henri Mondor (E.T.), Assistance Publique-Hôpitaux de Paris, France
| | - Mireille Mapouata
- From the Cardiology Department (J.-L.G., B.L.), Emergency Department (S.B.), and SAMU 78 (Y.L.), Versailles Hospital (André Mignot), Le Chesnay, France; Paris Cardiovascular Research Center, INSERM Unit 970, France (N.K., M.T., C.S., X.J.); Cardiology Department, European Georges Pompidou University Hospital (N.K., C.S., X.J.), Cardiology Department, University Hospital Cochin (O.V.), and Cardiology Department, University Hospital Henri Mondor (E.T.), Assistance Publique-Hôpitaux de Paris, France
| | - Hakim Benamer
- From the Cardiology Department (J.-L.G., B.L.), Emergency Department (S.B.), and SAMU 78 (Y.L.), Versailles Hospital (André Mignot), Le Chesnay, France; Paris Cardiovascular Research Center, INSERM Unit 970, France (N.K., M.T., C.S., X.J.); Cardiology Department, European Georges Pompidou University Hospital (N.K., C.S., X.J.), Cardiology Department, University Hospital Cochin (O.V.), and Cardiology Department, University Hospital Henri Mondor (E.T.), Assistance Publique-Hôpitaux de Paris, France
| | - Christophe Caussin
- From the Cardiology Department (J.-L.G., B.L.), Emergency Department (S.B.), and SAMU 78 (Y.L.), Versailles Hospital (André Mignot), Le Chesnay, France; Paris Cardiovascular Research Center, INSERM Unit 970, France (N.K., M.T., C.S., X.J.); Cardiology Department, European Georges Pompidou University Hospital (N.K., C.S., X.J.), Cardiology Department, University Hospital Cochin (O.V.), and Cardiology Department, University Hospital Henri Mondor (E.T.), Assistance Publique-Hôpitaux de Paris, France
| | - Philippe Garot
- From the Cardiology Department (J.-L.G., B.L.), Emergency Department (S.B.), and SAMU 78 (Y.L.), Versailles Hospital (André Mignot), Le Chesnay, France; Paris Cardiovascular Research Center, INSERM Unit 970, France (N.K., M.T., C.S., X.J.); Cardiology Department, European Georges Pompidou University Hospital (N.K., C.S., X.J.), Cardiology Department, University Hospital Cochin (O.V.), and Cardiology Department, University Hospital Henri Mondor (E.T.), Assistance Publique-Hôpitaux de Paris, France
| | - Olivier Varenne
- From the Cardiology Department (J.-L.G., B.L.), Emergency Department (S.B.), and SAMU 78 (Y.L.), Versailles Hospital (André Mignot), Le Chesnay, France; Paris Cardiovascular Research Center, INSERM Unit 970, France (N.K., M.T., C.S., X.J.); Cardiology Department, European Georges Pompidou University Hospital (N.K., C.S., X.J.), Cardiology Department, University Hospital Cochin (O.V.), and Cardiology Department, University Hospital Henri Mondor (E.T.), Assistance Publique-Hôpitaux de Paris, France
| | - Franck Barbou
- From the Cardiology Department (J.-L.G., B.L.), Emergency Department (S.B.), and SAMU 78 (Y.L.), Versailles Hospital (André Mignot), Le Chesnay, France; Paris Cardiovascular Research Center, INSERM Unit 970, France (N.K., M.T., C.S., X.J.); Cardiology Department, European Georges Pompidou University Hospital (N.K., C.S., X.J.), Cardiology Department, University Hospital Cochin (O.V.), and Cardiology Department, University Hospital Henri Mondor (E.T.), Assistance Publique-Hôpitaux de Paris, France
| | - Emmanuel Teiger
- From the Cardiology Department (J.-L.G., B.L.), Emergency Department (S.B.), and SAMU 78 (Y.L.), Versailles Hospital (André Mignot), Le Chesnay, France; Paris Cardiovascular Research Center, INSERM Unit 970, France (N.K., M.T., C.S., X.J.); Cardiology Department, European Georges Pompidou University Hospital (N.K., C.S., X.J.), Cardiology Department, University Hospital Cochin (O.V.), and Cardiology Department, University Hospital Henri Mondor (E.T.), Assistance Publique-Hôpitaux de Paris, France
| | - François Funck
- From the Cardiology Department (J.-L.G., B.L.), Emergency Department (S.B.), and SAMU 78 (Y.L.), Versailles Hospital (André Mignot), Le Chesnay, France; Paris Cardiovascular Research Center, INSERM Unit 970, France (N.K., M.T., C.S., X.J.); Cardiology Department, European Georges Pompidou University Hospital (N.K., C.S., X.J.), Cardiology Department, University Hospital Cochin (O.V.), and Cardiology Department, University Hospital Henri Mondor (E.T.), Assistance Publique-Hôpitaux de Paris, France
| | - Gaëtan Karrillon
- From the Cardiology Department (J.-L.G., B.L.), Emergency Department (S.B.), and SAMU 78 (Y.L.), Versailles Hospital (André Mignot), Le Chesnay, France; Paris Cardiovascular Research Center, INSERM Unit 970, France (N.K., M.T., C.S., X.J.); Cardiology Department, European Georges Pompidou University Hospital (N.K., C.S., X.J.), Cardiology Department, University Hospital Cochin (O.V.), and Cardiology Department, University Hospital Henri Mondor (E.T.), Assistance Publique-Hôpitaux de Paris, France
| | - Yves Lambert
- From the Cardiology Department (J.-L.G., B.L.), Emergency Department (S.B.), and SAMU 78 (Y.L.), Versailles Hospital (André Mignot), Le Chesnay, France; Paris Cardiovascular Research Center, INSERM Unit 970, France (N.K., M.T., C.S., X.J.); Cardiology Department, European Georges Pompidou University Hospital (N.K., C.S., X.J.), Cardiology Department, University Hospital Cochin (O.V.), and Cardiology Department, University Hospital Henri Mondor (E.T.), Assistance Publique-Hôpitaux de Paris, France
| | - Christian Spaulding
- From the Cardiology Department (J.-L.G., B.L.), Emergency Department (S.B.), and SAMU 78 (Y.L.), Versailles Hospital (André Mignot), Le Chesnay, France; Paris Cardiovascular Research Center, INSERM Unit 970, France (N.K., M.T., C.S., X.J.); Cardiology Department, European Georges Pompidou University Hospital (N.K., C.S., X.J.), Cardiology Department, University Hospital Cochin (O.V.), and Cardiology Department, University Hospital Henri Mondor (E.T.), Assistance Publique-Hôpitaux de Paris, France
| | - Xavier Jouven
- From the Cardiology Department (J.-L.G., B.L.), Emergency Department (S.B.), and SAMU 78 (Y.L.), Versailles Hospital (André Mignot), Le Chesnay, France; Paris Cardiovascular Research Center, INSERM Unit 970, France (N.K., M.T., C.S., X.J.); Cardiology Department, European Georges Pompidou University Hospital (N.K., C.S., X.J.), Cardiology Department, University Hospital Cochin (O.V.), and Cardiology Department, University Hospital Henri Mondor (E.T.), Assistance Publique-Hôpitaux de Paris, France
| |
Collapse
|
28
|
Georges JL, Belle L, Etard C, Azowa JB, Albert F, Pansieri M, Monsegu J, Barbou F, Trouillet C, Leddet P, Livarek B, Marcaggi X, Hanssen M, Cattan S. Radiation Doses to Patients in Interventional Coronary Procedures-Estimation of Updated National Reference Levels by Dose Audit. Radiat Prot Dosimetry 2017; 175:17-25. [PMID: 27624893 DOI: 10.1093/rpd/ncw261] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 08/16/2016] [Accepted: 08/12/2016] [Indexed: 06/06/2023]
Abstract
The objective of this study was to estimate the French national updated reference levels (RLs) for coronary angiography (CA) and percutaneous coronary intervention (PCI) by a dose audit from a large data set of unselected procedures and in standard-sized patients. Kerma-area product (PKA), air kerma at interventional point (Ka,r), fluoroscopy time (FT), and the number of registered frames (NFs) and runs (NRs) were collected from 51 229 CAs and 42 222 PCIs performed over a 12-month period at 61 French hospitals. RLs estimated by the 75th percentile in CAs and PCIs performed in unselected patients were 36 and 78 Gy.cm² for PKA, 498 and 1285 mGy for Ka,r, 6 and 15 min for FT, and 566 and 960 for NF, respectively. These values were consistent with the RLs calculated in standard-sized patients. The large difference in dose between sexes leads us to propose specific RLs in males and females. The results suggest a trend for a time-course reduction in RLs for interventional coronary procedures.
Collapse
Affiliation(s)
- Jean-Louis Georges
- Service de Cardiologie, Centre Hospitalier de Versailles, 78150 Le Chesnay, France
- Collège National des Cardiologues des Hôpitaux, Paris, France
| | - Loic Belle
- Collège National des Cardiologues des Hôpitaux, Paris, France
- Service de Cardiologie, Centre Hospitalier d'Annecy-Genevois, Annecy, France
| | - Cécile Etard
- Institut de Radioprotection et de Sureté Nucléaire, PRP-HOM/SER, BP17, 92262 Fontenay-aux-Roses, France
| | - Jean-Baptiste Azowa
- Service de Cardiologie, Centre Hospitalier de Versailles, 78150 Le Chesnay, France
| | - Franck Albert
- Collège National des Cardiologues des Hôpitaux, Paris, France
- Service de Cardiologie, Hôpital Louis Pasteur, Chartres, France
| | - Michel Pansieri
- Collège National des Cardiologues des Hôpitaux, Paris, France
- Service de Cardiologie, Centre Hospitalier d'Avignon, Avignon, France
| | - Jacques Monsegu
- Collège National des Cardiologues des Hôpitaux, Paris, France
- Service de Cardiologie, Groupe Hospitalier Mutualiste, Grenoble, France
| | - Franck Barbou
- Collège National des Cardiologues des Hôpitaux, Paris, France
- Service de Cardiologie, Hôpital d'instruction des Armées du Val de Grâce, Paris, France
| | - Charlotte Trouillet
- Collège National des Cardiologues des Hôpitaux, Paris, France
- Service de Cardiologie, Groupe Hospitalier de la Rochelle-Ré-Aunis, La Rochelle, France
| | - Pierre Leddet
- Collège National des Cardiologues des Hôpitaux, Paris, France
- Service de Cardiologie, Centre Hospitalier de Haguenau, Haguenau, France
| | - Bernard Livarek
- Service de Cardiologie, Centre Hospitalier de Versailles, 78150 Le Chesnay, France
- Collège National des Cardiologues des Hôpitaux, Paris, France
| | - Xavier Marcaggi
- Collège National des Cardiologues des Hôpitaux, Paris, France
- Service de Cardiologie, Centre Hospitalier Jacques Lacarin, Vichy, France
| | - Michel Hanssen
- Collège National des Cardiologues des Hôpitaux, Paris, France
- Service de Cardiologie, Centre Hospitalier de Haguenau, Haguenau, France
| | - Simon Cattan
- Collège National des Cardiologues des Hôpitaux, Paris, France
- Service de Cardiologie, Groupe Hospitalier Intercommunal Le Raincy-Montfermeil, Montfermeil, France
| |
Collapse
|
29
|
Georges JL, Belle L, Meunier L, Dechery T, Khalifé K, Pecheux M, Elhaddad S, Amabile N, Pansieri M, Ballout J, Marchand X, Rouault G, Leddet P, Nugue O, Lucke N, Cattan S. Radial versus femoral access for coronary angiography and intervention is associated with lower patient radiation exposure in high-radial-volume centres: Insights from the RAY’ACT-1 study. Arch Cardiovasc Dis 2017; 110:179-187. [DOI: 10.1016/j.acvd.2016.09.002] [Citation(s) in RCA: 8] [Impact Index Per Article: 1.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 06/25/2016] [Revised: 08/19/2016] [Accepted: 09/13/2016] [Indexed: 10/20/2022]
|
30
|
Huisman MV, Rothman KJ, Paquette M, Teutsch C, Diener HC, Dubner SJ, Halperin JL, Ma CS, Zint K, Elsaesser A, Bartels DB, Lip GY, Abban D, Abdul N, Abelson M, Ackermann A, Adams F, Adams L, Adragão P, Ageno W, Aggarwal R, Agosti S, Marin JA, Aguilar F, Aguilar Linares JA, Aguinaga L, Ahmad Z, Ainsworth P, Al Ghalayini K, Al Ismail S, Alasfar A, Alawwa A, Al-Dallow R, Alderson L, Alexopoulos D, Ali A, Ali M, Aliyar P, Al-Joundi T, Al Mahameed S, Almassi H, Almuti K, Al-Obaidi M, Alshehri M, Altmann U, Alves AR, Al-Zoebi A, Amara W, Amelot M, Amjadi N, Ammirati F, Andrawis N, Angoulvant D, Annoni G, Ansalone G, Antonescu SA, Ariani M, Arias JC, Armero S, Arora R, Arora C, Ashcraft W, Aslam MS, Astesiano A, Audouin P, Augenbraun C, Aydin S, Azar R, Azim A, Aziz S, Backes LM, Baig M, Bains S, Bakbak A, Baker S, Bakhtiar K, Bala R, Banayan J, Bandh S, Bando S, Banerjee S, Bank A, Barbarash O, Barón G, Barr C, Barrera C, Barton J, Kes VB, Baula G, Bayeh H, Bazargani N, Behrens S, Bell A, Benezet-Mazuecos J, Benhalima B, Berdagué P, Berg van den B, Bergen van P, Berngard E, Bernstein R, Yao J, Yarlagadda C, Yeh KH, Yotov Y, Yvorra S, Zahn R, Zamorano J, Zanini R, Zarich S, Zebrack J, Berrospi P, Zenin S, Zeuthen EL, Zhang X, Zhang Q, Zhang D, Zhang D, Zhang H, Zhao S, Zhao X, Zheng Y, Berti S, Zheng Q, Zhou J, Zhou J, Zimmermann SL, Zimmermann R, Zukerman LS, Zwaan van der C, Bertomeu V, Berz A, Bettencourt P, Betzu R, Beyer-Westendorf J, Bhagwat R, Black T, Blanco Ibaceta JH, Bloom S, Blumberg E, Bo M, Bockisch V, Bøhmer E, Bongiorni MG, Boriani G, Bosch R, Boswijk D, Bott J, Bottacchi E, Kalan MB, Brandes A, Bratland B, Brautigam D, Breton N, Brouwers P, Browne K, Bruguera J, Brunehaut M, Brunschwig C, Buathier H, Buhl A, Bullinga J, Butcher K, Cabrera Honorio JW, Caccavo A, Cadinot D, Cai S, Calvi V, Camm J, Candeias R, Capo J, Capucci A, Cardoso JN, Duarte Vera YC, Carlson B, Carvalho P, Cary S, Casanova R, Casu G, Cattan S, Cavallini C, Cayla G, Cha TJ, Cha KS, Chaaban S, Chae JK, Challappa K, Chand S, Chandrashekar H, Chang M, Charbel P, Chartier L, Chatterjee K, Cheema A, Chen SA, Chevallereau P, Chiang FT, Chiarella F, Chih-Chan L, Cho YK, Choi DJ, Chouinard G, Danny, Chow HF, Chrysos D, Chumakova G, José Roberto Chuquiure Valenzuela EJ, Cieza-Lara T, Nica VC, Ciobotaru V, Cislowski D, Citerne O, Claus M, Clay A, Clifford P, Cohen S, Cohen A, Colivicchi F, Collins R, Compton S, Connors S, Conti A, Buenostro GC, Coodley G, Cooper M, Corbett L, Corey O, Coronel J, Corrigan J, Cotrina Pereyra RY, Cottin Y, Coutu B, Cracan A, Crean P, Crenshaw J, Crijns H, Crump C, Cucher F, Cudmore D, Cui L, Culp J, Darius H, Dary P, Dascotte O, Dauber I, Davee T, Davies R, Davis G, Davy JM, Dayer M, De La Briolle A, de Mora M, De Teresa E, De Wolf L, Decoulx E, Deepak S, Defaye P, Del-Carpio Munoz F, Brkljacic DD, Deluche L, Destrac S, Deumite N, Di Legge S, Dibon O, Diemberger I, Dillinger J, Dionísio P, Naydenov S, Dotani I, Dotcheva E, D'Souza A, Dubrey S, Ducrocq X, Dupljakov D, DuThinh V, Dutra OP, Dutta D, Duvilla N, Dy J, Dziewas R, Eaton C, Eaves W, Ebinger M, Eck van J, Edwards T, Egocheaga I, Ehrlich C, Eisenberg S, El Hallak A, El Jabali A, El Mahmoud R, El Shahawy M, Eldadah Z, Elghelbazouri F, Elhag O, El-Hamdani M, Elias D, Ellery A, El-Sayed H, Elvan A, Erickson B, Espaliat E, Essandoh L, Everington T, Evonich R, Ezhov A, Fácila L, Farsad R, Fayard M, Fedele F, Gomes Ferreira LG, Ferreira D, Santos JF, Ferrier A, Finsen A, First B, Fisher R, Floyd J, Folk T, Fonseca C, Fonseca L, Forman S, Forsgren M, Foster M, Foster N, Frais M, Frandsen B, Frappé T, Freixa R, French W, Freydlin M, Frickel S, Fruntelata AG, Fujii S, Fujino Y, Fukunaga H, Furukawa Y, Gabelmann M, Gabris M, Gadsbøll N, Galin P, Galinier M, Ganim R, Garcia R, Quintana AG, Gartenlaub O, Genz C, Georger F, Georges JL, Georgeson S, Ghanbasha A, Giedrimas E, Gierba M, Gillespie E, Giniger A, Gkotsis A, Gmehling J, Gniot J, Goethals P, Goldberg R, Goldmann B, Goldscher D, Golitsyn S, Gomez Lopez EA, Gomez Mesa JE, Gonzalez E, Cocina EG, Juanatey CG, Gorbunov V, Gordon B, Gorka H, Gornick C, Gorog D, Goss F, Götte A, Goube P, Goudevenos I, Goulden D, Graham B, Grande A, Greco C, Green M, Greer G, Gremmler U, Grena P, Grinshstein Y, Grond M, Gronda E, Grondin F, Grönefeld G, Groot de J, Guardigli G, Guarnieri T, Caiedo CG, Guignier A, Gulizia M, Gumbley M, Gupta D, Hack T, Haerer W, Hakas J, Hall C, Hampsey J, Hananis G, Hanbali B, Handel F, Hargrove J, Hargroves D, Harris K, Hartley D, Haruna T, Hata Y, Hayek E, Healey J, Hearne S, Heggelund G, Hemels M, Hemery Y, Henein S, Henz B, Her SH, Hermany P, Hernandes ME, Higashino Y, Hill M, Hisadome T, Hishida E, Hitchcock J, Hoffer E, Hoghton M, Holmes C, Hong SK, Houppe Nousse MP, Howard V, Hsu LF, Huang CH, Huckins D, Huehnergarth K, Huizenga A, Huntley R, Hussein G, Hwang GS, Igbokidi O, Iglesias I, Ikpoh M, Imberti D, Ince H, Indolfi C, Ionova T, Ip J, Irles D, Iseki H, Ismail Y, Israel N, Isserman S, Iteld B, Ivanchura G, Iyer R, Iyer V, Iza Villanueva RO, Jackson-Voyzey E, Jaffrani N, Jäger F, Jain M, James M, Jamon Y, Jang SW, Pereira Jardim CA, Jarmukli N, Jeanfreau R, Jenkins R, Jiang X, Jiang H, Jiang T, Jiang N, Jimenez J, Jobe R, Joffe I, Johansson B, Jones N, Moura Jorge JC, Jouve B, Jundi M, Jung W, Jung BC, Jung KT, Kabbani S, Kabour A, Kafkala C, Kajiwara K, Kalinina L, Kampus P, Kanda J, Kapadia S, Karim A, Karolyi L, Kashou H, Kastrup A, Katsivas A, Kaufman E, Kawai K, Kawajiri K, Kazmierski J, Keeling P, Kerfes GA, Kerr Saraiva JF, Ketova G, Khaira A, Khalid M, Khludeeva E, Khripun A, Kim DI, Kim DK, Kim NH, Kim KS, Kim YH, Kim JB, Kim JS, Kim JS, Kinova E, Klein A, Kleinschnitz C, Kmetzo J, Kneller GL, Knezevic A, Koch S, Koenig K, Angela Koh SM, Köhrmann M, Koons J, Korabathina R, Korennova O, Koschutnik M, Kosinski E, Kovacic D, Kowalczyk J, Koziolova N, Kragten J, Krause LU, Kreidieh I, Krenning B, Krishnaswamy K, Krysiak W, Kuck KH, Kumar S, Kümler T, Kuniss M, Kuo JY, Küppers A, Kurrelmeyer K, Kwan T, Kyo E, Labovitz A, Lacroix A, Lam A, Lanas Zanetti FT, Landau C, Landini G, Lang W, Larsen TB, Laske V, Lavandier K, Law N, Lee MH, Lee D, Leitão A, Lejay D, Lelonek M, Lenarczyk R, Leprince P, Lequeux B, Leschke M, Ley N, Li Z, Li Y, Li X, Li Z, Li W, Liang J, Lieber I, Lillestol M, Limon Rodriguez RH, Lin H, Lip G, Litchfield J, Liu Z, Liu X, Liu Y, Liu F, Liu W, Llamas Esperon GA, Llisterri JL, Lo T, Lo E, Lobos JM, Lodde BP, Loiselet P, López-Sendón J, Lorga Filho AM, Lori I, Luo M, Lupovitch S, Lyrer P, Zuhairy HM, Ma C, Ma G, Ma H, Madariaga I, Maeno K, Magnin D, Mahmood S, Mahood K, Maid G, Mainigi S, Makaritsis K, Maldonado Villalon JA, Malhotra R, Malik A, Mallecourt C, Mallik R, Manning R, Manolis A, Mantas I, Manzur Jattin FG, Marcionni N, Marín F, Santana AM, Martinez J, Martinez L, Maskova P, Hernández NM, Matskeplishvili S, Matsuda K, Mavri A, May E, Mayer N, Mazon P, McClure J, McCormack T, McGarity W, McGuire M, McIntyre H, McLaughlin P, McLaurin B, Medina Palomino FA, Mehta P, Mehzad R, Meinel A, Melandri F, Mena A, Meno H, Menzies D, Metcalf K, Meyer B, Miarka J, Mibach F, Michalski D, Michel P, Chreih RM, Mikdadi G, Mikhail M, Mikus M, Milicic D, Militaru C, Miller G, Milonas C, Minescu B, Mintale I, Miralles A, Mirault T, Mistry D, Mitchell G, Miu NV, Miyamoto N, Moccetti T, Mohammed A, Nor AM, Molina de Salazar DI, Molon G, Molony D, Mondillo S, Mont L, Moodley R, Moore R, Ribeiro Moreira DA, Mori K, Moriarty A, Morka J, Moschos N, Mota Gomes MA, Mousallem N, Moya A, Mügge A, Mulhearn T, Muller JJ, Muresan CM, Muse D, Musial W, Musumeci F, Nadar V, Nageh T, Nair P, Nakagawa H, Nakamura Y, Nakayama T, Nam KB, Napalkov D, Natarajan I, Nayak H, Nechvatal L, Neiman J, Nerheim P, Neuenschwander FC, Nishida K, Nizov A, Novikova T, Novo S, Nowalany-Kozielska E, Nsah E, Nunez Fragoso JC, Nyvad O, de Los Rios Ibarra MO, O'Donnell M, O'Donnell P, Oh DJ, Oh YS, Daniel Oh CT, O'Hara G, Oikonomou K, Olalla JJ, Olivari Z, Oliver R, Olympios C, Osborne J, Osca J, Osman R, Osunkoya A, Padanilam B, Panchenko E, Pandey AS, Vicenzo de Paola AA, Paraschos A, Pardell H, Park HW, Park JS, Parkash R, Parker I, Parrens E, Parris R, Passamonti E, Patel J, Patel R, Pentz WH, Persic V, Perticone F, Peters P, Petkar S, Pezo LF, Pham D, Cao Phai GP, Phlaum S, Pineau J, Pineda-Velez A, Pini R, Pinter A, Pinto F, Pirelli S, Pivac N, Pizzini AM, Pocanic D, Calin Podoleanu CG, Polanczyk CA, Polasek P, Poljakovic Z, Pollock S, Polo J, Poock J, Poppert H, Porro Y, Pose A, Poulain F, Poulard JE, Pouzar J, Povolny P, Pozzer D, Pras A, Prasad N, Prevot S, Protasov K, Prunier L, Puleo J, Pye M, Qaddoura F, Quedillac JM, Raev D, Rahimi S, Raisaro A, Rama B, Ranadive N, Randall K, Ranjith N, Raposo N, Rashid H, Raters C, Rauch-Kroehnert U, Rebane T, Regner S, Renzi M, Reyes Rocha MA, Reza S, Ria L, Richter D, Rickli H, Rickner K, Rieker W, Rigo F, Ripoll T, Fonteles Ritt LE, Roberts D, Pascual CR, Briones IR, Reyes HR, Roelke M, Roman M, Romeo F, Ronner E, Ronziere T, Rooyer F, Rosenbaum D, Roth S, Rozkova N, Rubacek M, Rubalcava F, Rubanenko O, Rubin A, Borret MR, Rybak K, Sabbour H, Morales OS, Sakai T, Salacata A, Salecker I, Salem A, Salfity M, Salguero R, Salvioni A, Samson M, Sanchez G, Sandesara C, Saporito WF, Sasaoka T, Sattar P, Savard D, Scala PJ, Scemama J, Schaupp T, Schellinger P, Scherr C, Schmitz KH, Schmitz B, Schmitz L, Schnitzler R, Schnupp S, Schoeniger P, Schön N, Schuster S, Schwimmbeck P, Seamark C, Seebass R, Seidl KH, Seidman B, Sek J, Sekaran L, Seko Y, Sepulveda Varela PA, Sevilla B, Shah V, Shah A, Shah N, Shah A, Shanes J, Sharareh A, Sharma VK, Shaw L, Shimizu Y, Shimomura H, Shin DG, Shin ES, Shite J, Shoukfeh M, Shoultz C, Silver F, Sime I, Simmers T, Singal D, Singh N, Siostrzonek P, Sirajuddin M, Skeppholm M, Smadja D, Smith R, Smith D, Soda H, Sofley CW, Sokal A, Sotolongo R, de Souza OF, Sparby JA, Spinar J, Sprigings D, Spyropoulos A, Stakos D, Steinberg A, Steinwender C, Stergiou G, Stites HW, Stoikov A, Strasser R, Streb W, Styliadis I, Su G, Su X, Suarez RM, Sudnik W, Sueyoshi A, Sukles K, Sun L, Suneja R, Svensson P, Ziekenhuis A, Szavits-Nossan J, Taggeselle J, Takagi Y, Takhar A, Tallet J, Tamm A, Tanaka S, Tanaka K, Tang A, Tang S, Tassinari T, Tayama S, Tayebjee M, Tebbe U, Teixeira J, Tesloianu DN, Tessier P, The S, Thevenin J, Thomas H, Timsit S, Topkis R, Torosoff M, Touze E, Traissac T, Trendafilova E, Troyan B, Tsai WK, Tse HF, Tsutsui H, Tsutsui T, Tuininga Y, Turakhia M, Turk S, Turner W, Tveit A, Twiddy S, Tytus R, Ukrainski G, Valdovinos Chavez SB, Van De Graaff E, Vanacker P, Vardas P, Vargas M, Vassilikos V, Vazquez J, Venkataraman A, Verdecchia P, Vester EG, Vial H, Vinereanu D, Vlastaris A, Vogel C, vom Dahl J, von Mering M, Vora K, Wakefield P, Walia J, Walter T, Wang M, Wang N, Wang F, Wang X, Wang Z, Wang KY, Watanabe K, Wei J, Weimar C, Weinrich R, Wen MS, Wheelan K, Wicke J, Wiemer M, Wild B, Wilke A, Willems S, Williams M, Williams D, Winkler A, Wirtz JH, Witzenbichler B, Wong DH, Lawrence Wong KS, Wong B, Wozakowska-Kaplon B, Wu Z, Wu S, Wyatt N, Xu Y, Xu X, Yamada A, Yamamoto K, Yamanoue H, Yamashita T, Bryan Yan PY, Yang Y, Yang T. The Changing Landscape for Stroke Prevention in AF. J Am Coll Cardiol 2017; 69:777-785. [DOI: 10.1016/j.jacc.2016.11.061] [Citation(s) in RCA: 215] [Impact Index Per Article: 30.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 09/19/2016] [Revised: 11/04/2016] [Accepted: 11/10/2016] [Indexed: 12/13/2022]
|
31
|
Petroni T, Zaman A, Georges JL, Hammoudi N, Berman E, Segev A, Juliard JM, Barthelemy O, Silvain J, Choussat R, Le Feuvre C, Helft G. Primary percutaneous coronary intervention for ST elevation myocardial infarction in nonagenarians. Heart 2016; 102:1648-54. [PMID: 27411839 PMCID: PMC5099211 DOI: 10.1136/heartjnl-2015-308905] [Citation(s) in RCA: 15] [Impact Index Per Article: 1.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 10/26/2015] [Accepted: 04/29/2016] [Indexed: 12/02/2022] Open
Abstract
Objective To assess outcomes following primary percutaneous coronary intervention (PCI) for ST-segment elevation acute myocardial infarction (STEMI) in nonagenarian patients. Methods We conducted a multicentre retrospective study between 2006 and 2013 in five international high-volume centres and included consecutive all-comer nonagenarians treated with primary PCI for STEMI. There were no exclusion criteria. We enrolled 145 patients and collected demographic, clinical and procedural data. Severe clinical events and mortality at 6 months and 1 year were assessed. Results Cardiogenic shock was present at admission in 21%. Median (IQR) delay between symptom onset and balloon was 3.7 (2.4–5.6) hours and 60% of procedures were performed through the transradial approach. Successful revascularisation of the culprit vessel was obtained in 86% of the cases (thrombolysis in myocardial infarction flow of 2 or 3). Major or clinically relevant bleeding was observed in 4% of patients. Median left ventricular ejection fraction post PCI was 41.5% (32.0–50.0). The in-hospital mortality was 24%, with 6 months and 1-year survival rates of 61% and 53%, respectively. Conclusions In our study, primary PCI in nonagenarians with STEMI was achieved and feasible through a transradial approach. It is associated with a high rate of reperfusion of the infarct-related artery and 53% survival at 1 year. These results suggest that primary PCI may be offered in selected nonagenarians with acute myocardial infarction.
Collapse
Affiliation(s)
- Thibaut Petroni
- Cardiology Institute, Pitié-Salpêtrière Hospital, UPMC, APHP, Paris, France
| | - Azfar Zaman
- Freeman Hospital and Institute of Cellular Medicine, Newcastle University, Newcastle Upon Tyne, UK
| | - Jean-Louis Georges
- Centre Hospitalier de Versailles, André Mignot Hospital, Le Chesnay, France
| | - Nadjib Hammoudi
- Cardiology Institute, Pitié-Salpêtrière Hospital, UPMC, APHP, Paris, France
| | - Emmanuel Berman
- Cardiology Institute, Pitié-Salpêtrière Hospital, UPMC, APHP, Paris, France
| | - Amit Segev
- Heart Institute, Chaim Sheba Medical Center, Tel-Hashomer, Israël
| | | | - Olivier Barthelemy
- Cardiology Institute, Pitié-Salpêtrière Hospital, UPMC, APHP, Paris, France
| | - Johanne Silvain
- Cardiology Institute, Pitié-Salpêtrière Hospital, UPMC, APHP, Paris, France
| | - Rémi Choussat
- Cardiology Institute, Pitié-Salpêtrière Hospital, UPMC, APHP, Paris, France
| | - Claude Le Feuvre
- Cardiology Institute, Pitié-Salpêtrière Hospital, UPMC, APHP, Paris, France
| | - Gérard Helft
- Cardiology Institute, Pitié-Salpêtrière Hospital, UPMC, APHP, Paris, France
| |
Collapse
|
32
|
Llitjos JF, Daviaud F, Grimaldi D, Legriel S, Georges JL, Guerot E, Bedos JP, Fagon JY, Charpentier J, Mira JP. Ilio-psoas hematoma in the intensive care unit: a multicentric study. Ann Intensive Care 2016; 6:8. [PMID: 26782681 PMCID: PMC4717128 DOI: 10.1186/s13613-016-0106-z] [Citation(s) in RCA: 21] [Impact Index Per Article: 2.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/28/2015] [Accepted: 01/04/2016] [Indexed: 02/06/2023] Open
Abstract
Background
Clinical features and outcomes of patients with spontaneous ilio-psoas hematoma (IPH) in intensive care units (ICUs) are poorly documented. The objectives of this study were to determine epidemiological, clinical, biological and management characteristics of ICU patients with IPH. Methods
We conducted a retrospective multicentric study in three French ICUs from January 2006 to December 2014. We included IPH diagnosed both at admission and during ICU stay. Surgery and embolization were available 24 h a day for each center, and therapeutic decisions were undertaken after pluridisciplinary discussion. All IPHs were diagnosed using CT scan. Results During this period, we identified 3.01 cases/1000 admissions. The mortality rate of the 77 included patients was 30 %. In multivariate analysis, we observed that mortality was independently associated with SAPS II (OR 1.1, 95 % CI [1.013–1.195], p = 0.02) and with the presence of hemorrhagic shock (OR 67.1, 95 % CI [2.6–1691], p = 0.01). We found IPH was related to anticoagulation therapy in 56 cases (72 %), with guideline-concordant reversal performed in 33 % of patients. We did not found any association between anticoagulant therapy type and outcome. Conclusion We found IPH is an infrequent disease, with a high mortality rate of 30 %, mostly related to anticoagulation therapy and usually affecting the elderly. Management of anticoagulation-related IPH includes a high rate of no reversal of 38 %.
Collapse
Affiliation(s)
- J F Llitjos
- Medical Intensive Care Unit, Cochin Hospital, Groupe Hospitalier Cochin Broca Hôtel-Dieu, Assistance Publique des Hôpitaux de Paris, 27 rue du Faubourg Saint-Jacques, 75014, Paris, France. .,Faculté de Médecine, Université Paris Descartes, Sorbonne Paris Cité, 15 rue de l'Ecole de Médecine, 75006, Paris, France.
| | - F Daviaud
- Medical Intensive Care Unit, Cochin Hospital, Groupe Hospitalier Cochin Broca Hôtel-Dieu, Assistance Publique des Hôpitaux de Paris, 27 rue du Faubourg Saint-Jacques, 75014, Paris, France.,Faculté de Médecine, Université Paris Descartes, Sorbonne Paris Cité, 15 rue de l'Ecole de Médecine, 75006, Paris, France
| | - D Grimaldi
- Medical Intensive Care Unit, Cochin Hospital, Groupe Hospitalier Cochin Broca Hôtel-Dieu, Assistance Publique des Hôpitaux de Paris, 27 rue du Faubourg Saint-Jacques, 75014, Paris, France.,Faculté de Médecine, Université Paris Descartes, Sorbonne Paris Cité, 15 rue de l'Ecole de Médecine, 75006, Paris, France
| | - S Legriel
- Intensive Care Unit, Hôpital de Versailles - Site André Mignot, 177 rue de Versailles, 78150, Le Chesnay Cedex, France
| | - J L Georges
- Cardiology, Hôpital de Versailles - Site André Mignot, 177 rue de Versailles, 78150, Le Chesnay Cedex, France
| | - E Guerot
- Faculté de Médecine, Université Paris Descartes, Sorbonne Paris Cité, 15 rue de l'Ecole de Médecine, 75006, Paris, France.,Medical Intensive Care Unit, Hôpital Européen Georges Pompidou, AP-HP, Paris, France
| | - J P Bedos
- Intensive Care Unit, Hôpital de Versailles - Site André Mignot, 177 rue de Versailles, 78150, Le Chesnay Cedex, France
| | - J Y Fagon
- Faculté de Médecine, Université Paris Descartes, Sorbonne Paris Cité, 15 rue de l'Ecole de Médecine, 75006, Paris, France.,Medical Intensive Care Unit, Hôpital Européen Georges Pompidou, AP-HP, Paris, France
| | - J Charpentier
- Medical Intensive Care Unit, Cochin Hospital, Groupe Hospitalier Cochin Broca Hôtel-Dieu, Assistance Publique des Hôpitaux de Paris, 27 rue du Faubourg Saint-Jacques, 75014, Paris, France.,Faculté de Médecine, Université Paris Descartes, Sorbonne Paris Cité, 15 rue de l'Ecole de Médecine, 75006, Paris, France
| | - J P Mira
- Medical Intensive Care Unit, Cochin Hospital, Groupe Hospitalier Cochin Broca Hôtel-Dieu, Assistance Publique des Hôpitaux de Paris, 27 rue du Faubourg Saint-Jacques, 75014, Paris, France.,Faculté de Médecine, Université Paris Descartes, Sorbonne Paris Cité, 15 rue de l'Ecole de Médecine, 75006, Paris, France
| |
Collapse
|
33
|
Georges JL, Belle L, Azowa JB, Albert F, Pansieri M, Monsegu J, Cattan S. 0254: Updated reference levels for radiation doses to patients undergoing coronary angiography and coronary percutaneous interventions: the RAY’ACT2 study. Archives of Cardiovascular Diseases Supplements 2016. [DOI: 10.1016/s1878-6480(16)30012-x] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/22/2022]
|
34
|
Yayehd K, N'da NW, Belle L, Bataille V, Hanssen M, Leddet P, Aupetit JF, Commeau P, Filippi E, Georges JL, Albert F, Rangé G, Meimoun P, Marcaggi X, Baleynaud S, Nallet O, Dibie A, Barnay C, Jouve B, Legrand M, Cattan S, Mulak G, Simon T, Danchin N, Dujardin JJ. Management of Takotsubo cardiomyopathy in non-academic hospitals in France: The Observational French SyndromEs of TakoTsubo (OFSETT) study. Arch Cardiovasc Dis 2015; 109:4-12. [PMID: 26507532 DOI: 10.1016/j.acvd.2015.08.004] [Citation(s) in RCA: 15] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 04/16/2015] [Revised: 08/07/2015] [Accepted: 08/10/2015] [Indexed: 01/16/2023]
Abstract
BACKGROUND Takotsubo cardiomyopathy (TTC) is a rare condition characterized by a sudden temporary weakening of the heart. TTC can mimic acute myocardial infarction and is associated with a minimal release of myocardial biomarkers in the absence of obstructive coronary artery disease. AIMS To provide an extensive description of patients admitted to hospital for TTC throughout France and to study the management and outcomes of these patients. METHODS In 14 non-academic hospitals, we collected clinical, electrocardiographic, biological, psychological and therapeutic data in patients with a diagnosis of TTC according to the Mayo Clinic criteria. RESULTS Of 117 patients, 91.5% were women, mean ± SD age was 71.4 ± 12.1 years and the prevalence of risk factors was high (hypertension: 57.9%, dyslipidaemia: 33.0%, diabetes: 11.5%, obesity: 11.5%). The most common initial symptoms were chest pain (80.5%) and dyspnoea (24.1%). A triggering psychological event was detected in 64.3% of patients. ST-segment elevation was found in 41.7% of patients and T-wave inversion in 71.6%. Anterior leads were most frequently associated with ST-segment elevation, whereas T-wave inversion was more commonly associated with lateral leads, and Q-waves with septal leads. The ratio of peak B-type natriuretic peptide (BNP) or N-terminal prohormone BNP (NT-proBNP) level to peak troponin level was 1.01. No deaths occurred during the hospital phase. After 1 year of follow-up, 3 of 109 (2.8%) patients with available data died, including one cardiovascular death. Rehospitalizations occurred in 17.4% of patients: 2.8% due to acute heart failure and 14.7% due to non-cardiovascular causes. There was no recurrence of TTC. CONCLUSIONS This observational study of TTC included primarily women with atherosclerotic risk factors and mental stress. T-wave inversion was more common than ST-segment elevation. There were few adverse cardiovascular outcomes in these patients after 1-year follow-up.
Collapse
Affiliation(s)
- Komlavi Yayehd
- Department of Cardiology, Campus University Teaching Hospital, Lomé, Togo
| | - N'kenon W N'da
- Department of Cardiology, Campus University Teaching Hospital, Lomé, Togo
| | - Loïc Belle
- Department of Cardiology, Annecy Hospital, 74000 Annecy, France.
| | - Vincent Bataille
- Department of Cardiology and Epidemiology, Toulouse University Hospital, 31000 Toulouse, France
| | - Michel Hanssen
- Department of Cardiology, Haguenau Hospital, 67500 Haguenau, France
| | - Pierre Leddet
- Department of Cardiology, Haguenau Hospital, 67500 Haguenau, France
| | | | - Philippe Commeau
- Department of Cardiology, polyclinique Les Fleurs, 83190 Ollioules, France
| | - Emmanuelle Filippi
- Department of Cardiology, Bretagne-Atlantique Hospital, 56000 Vannes, France
| | | | - Franck Albert
- Department of Cardiology, Chartres Hospital, 28000 Chartres, France
| | - Grégoire Rangé
- Department of Cardiology, Chartres Hospital, 28000 Chartres, France
| | - Patrick Meimoun
- Department of Cardiology, Compiègne Hospital, 60200 Compiègne, France
| | - Xavier Marcaggi
- Department of Cardiology, Vichy Hospital, 03200 Vichy, France
| | - Serge Baleynaud
- Department of Cardiology, Bretagne Hospital, 56100 Lorient, France
| | - Olivier Nallet
- Department of Cardiology, Le Raincy-Montfermeil Intercity Hospital, 93370 Montfermeil, France
| | - Alain Dibie
- Institut mutualiste Montsouris, 75000 Paris, France
| | - Claude Barnay
- Department of Cardiology, Pays d'Aix Hospital, 13100 Aix-en-Provence, France
| | - Bernard Jouve
- Department of Cardiology, Pays d'Aix Hospital, 13100 Aix-en-Provence, France
| | - Maud Legrand
- Department of Cardiology, Le Mans Hospital, 72000 Le Mans, France
| | - Simon Cattan
- Department of Cardiology, Le Raincy-Montfermeil Intercity Hospital, 93370 Montfermeil, France
| | | | - Tabassome Simon
- Department of Clinical Pharmacology and Clinical Research, Saint-Antoine University Hospital, 75000 Paris, France
| | - Nicolas Danchin
- Department of Cardiology, Georges-Pompidou University Hospital, 75000 Paris, France
| | | | | |
Collapse
|
35
|
Helft G, Steg PG, Le Feuvre C, Georges JL, Carrie D, Dreyfus X, Furber A, Leclercq F, Eltchaninoff H, Falquier JF, Henry P, Cattan S, Sebagh L, Michel PL, Tuambilangana A, Hammoudi N, Boccara F, Cayla G, Douard H, Diallo A, Berman E, Komajda M, Metzger JP, Vicaut E. Stopping or continuing clopidogrel 12 months after drug-eluting stent placement: the OPTIDUAL randomized trial. Eur Heart J 2015; 37:365-74. [PMID: 26364288 DOI: 10.1093/eurheartj/ehv481] [Citation(s) in RCA: 60] [Impact Index Per Article: 6.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 07/09/2015] [Accepted: 08/24/2015] [Indexed: 11/12/2022] Open
Abstract
AIM This open-label, randomized, and multicentre trial tested the hypothesis that, on a background of aspirin, continuing clopidogrel would be superior to stopping clopidogrel at 12 months following drug-eluting stent (DES) implantation. METHODS AND RESULTS Patients (N = 1799) who had undergone placement of ≥1 DES for stable coronary artery disease or acute coronary syndrome were included in 58 French sites (January 2009-January 2013). Patients (N = 1385) free of major cardiovascular/cerebrovascular events or major bleeding and on aspirin and clopidogrel 12 months after stenting were eligible for randomization (1:1) between continuing clopidogrel 75 mg daily (extended-dual antiplatelet therapy, DAPT, group) or discontinuing clopidogrel (aspirin group). The primary outcome was net adverse clinical events defined as the composite of death, myocardial infarction, stroke, or major bleeding. Follow-up was planned from a minimum of 6 to a maximum of 36 months after randomization. Owing to slow recruitment, the study was stopped after enrolment of 1385 of a planned 1966 patients. Median follow-up after stenting was 33.4 months. The primary outcome occurred in 40 patients (5.8%) in the extended-DAPT group and 52 in the aspirin group (7.5%; hazard ratio 0.75, 95% confidence interval 0.50-1.28; P = 0.17). Rates of death were 2.3% in the extended-DAPT group and 3.5% in the aspirin group (HR 0.65, 95% CI 0.34-1.22; P = 0.18). Rates of major bleeding were identical (2.0%, P = 0.95). CONCLUSIONS Extended DAPT did not achieve superiority in reducing net adverse clinical events compared to 12 months of DAPT after DES placement. The power of the OPTIDUAL trial was however low and reduced by premature termination of enrolment. CLINICALTRIALSGOV NUMBER NCT00822536.
Collapse
Affiliation(s)
- Gérard Helft
- Institut de Cardiologie, Hôpital Pitié-Salpétrière, Assistance Publique Hôpitaux de Paris, Université Pierre et Marie Curie, boulevard de l'Hôpital, 75013 Paris, France IHU, Institute of Cardiometabolism and Nutrition, Hôpital Pitié-Salpétrière, Paris, France
| | - Philippe Gabriel Steg
- DHU FIRE, Université Paris-Diderot, Sorbonne-Paris-Cité, Paris, France Hôpital Bichat, Assistance Publique Hôpitaux de Paris, INSERM-U1148, Paris, France NHLI, Royal Brompton Hospital, Imperial College, London, UK
| | - Claude Le Feuvre
- Institut de Cardiologie, Hôpital Pitié-Salpétrière, Assistance Publique Hôpitaux de Paris, Université Pierre et Marie Curie, boulevard de l'Hôpital, 75013 Paris, France
| | | | - Didier Carrie
- Centre Hospitalier Universitaire Rangueil, Toulouse, France
| | | | - Alain Furber
- Centre Hospitalier Universitaire, Angers, France
| | | | - Hélène Eltchaninoff
- Centre Hospitalier Universitaire, Rouen, France INSERM U 1096, Rouen, France
| | | | - Patrick Henry
- Hôpital Lariboisière, Assistance Publique Hôpitaux de Paris, Paris 7, Paris, France
| | - Simon Cattan
- Centre Hospitalier Intercommunal Le Raincy-Montfermeil, Montfermeil, France
| | | | | | | | - Nadjib Hammoudi
- Institut de Cardiologie, Hôpital Pitié-Salpétrière, Assistance Publique Hôpitaux de Paris, Université Pierre et Marie Curie, boulevard de l'Hôpital, 75013 Paris, France IHU, Institute of Cardiometabolism and Nutrition, Hôpital Pitié-Salpétrière, Paris, France
| | - Franck Boccara
- Hôpital Saint-Antoine, Assistance Publique Hôpitaux de Paris, Paris Pierre et Marie Curie, Paris, France INSERM UMR_S 938, Paris, France
| | - Guillaume Cayla
- Centre Hospitalier Universitaire Nîmes, Université de Montpellier, Nîmes, France
| | - Hervé Douard
- Centre Hospitalier Universitaire, Bordeaux, France
| | - Abdourahmane Diallo
- Unité de Recherche Clinique Lariboisière St Louis Hôpital Fernand Widal, Assistance Publique Hôpitaux de Paris, Université Paris-Diderot, Paris, France
| | - Emmanuel Berman
- Institut de Cardiologie, Hôpital Pitié-Salpétrière, Assistance Publique Hôpitaux de Paris, Université Pierre et Marie Curie, boulevard de l'Hôpital, 75013 Paris, France
| | - Michel Komajda
- Institut de Cardiologie, Hôpital Pitié-Salpétrière, Assistance Publique Hôpitaux de Paris, Université Pierre et Marie Curie, boulevard de l'Hôpital, 75013 Paris, France IHU, Institute of Cardiometabolism and Nutrition, Hôpital Pitié-Salpétrière, Paris, France
| | - Jean-Philippe Metzger
- Institut de Cardiologie, Hôpital Pitié-Salpétrière, Assistance Publique Hôpitaux de Paris, Université Pierre et Marie Curie, boulevard de l'Hôpital, 75013 Paris, France
| | - Eric Vicaut
- Unité de Recherche Clinique Lariboisière St Louis Hôpital Fernand Widal, Assistance Publique Hôpitaux de Paris, Université Paris-Diderot, Paris, France PARTNERS/F-CRIN, Paris, France
| | | |
Collapse
|
36
|
Helft G, Georges JL, Mouranche X, Loyeau A, Spaulding C, Caussin C, Benamer H, Garot P, Livarek B, Teiger E, Varenne O, Monségu J, Mapouata M, Petroni T, Hammoudi N, Lambert Y, Dupas F, Laborne F, Lapostolle F, Lefort H, Juliard JM, Letarnec JY, Lamhaut L, Lebail G, Boche T, Jouven X, Bataille S. Outcomes of primary percutaneous coronary interventions in nonagenarians with acute myocardial infarction. Int J Cardiol 2015; 192:24-9. [DOI: 10.1016/j.ijcard.2015.04.227] [Citation(s) in RCA: 29] [Impact Index Per Article: 3.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 08/08/2014] [Revised: 03/23/2015] [Accepted: 04/29/2015] [Indexed: 01/25/2023]
|
37
|
Mafalanka F, Etard C, Rehel JL, Pesenti-Rossi D, Amrar-Vennier F, Baron N, Christiaens L, Convers-Domart R, Defez D, Douek P, Gaxotte V, Georges JL, Leygnac S, Ou P, Sablayrolles JL, Salvat C, Schouman-Claeys E, Sirol M, Aubert B. Establishment of diagnostic reference levels in cardiac CT in France: a need for patient dose optimisation. Radiat Prot Dosimetry 2015; 164:116-119. [PMID: 25342609 DOI: 10.1093/rpd/ncu317] [Citation(s) in RCA: 13] [Impact Index Per Article: 1.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 06/04/2023]
Abstract
The objective of this study was to propose diagnostic reference levels (DRLs) for coronary computed tomography angiography (CCTA), in the context of a large variability in patient radiation dose, and the lack of European recommendations. Volume Computed Tomography Dose Index (CTDIvol) and dose-length product (DLP) were collected from 460 CCTAs performed over a 3-month period at eight French hospitals. CCTAs (∼50 per centre) were performed using the routine protocols of the centres, and 64- to 320-detector CT scanners. ECG gating was prospective (n = 199) or retrospective (n = 261). The large gap in dose between these two modes required to propose specific DRLs: 26 and 44 mGy for CTDIvol, and 370 and 970 mGy cm for DLP, respectively. This study confirms the large variability in patient doses during CCTA and underlines the need for the optimisation of cardiac acquisition protocols. Availability of national DRLs should be mandatory in this setting.
Collapse
Affiliation(s)
- F Mafalanka
- Institut de Radioprotection et de Sureté Nucléaire, PRP-HOM/SER, BP17, Fontenay-aux-Roses 92262, France
| | - C Etard
- Institut de Radioprotection et de Sureté Nucléaire, PRP-HOM/SER, BP17, Fontenay-aux-Roses 92262, France
| | - J L Rehel
- Institut de Radioprotection et de Sureté Nucléaire, PRP-HOM/SER, BP17, Fontenay-aux-Roses 92262, France
| | | | | | - N Baron
- Hôpital Mignot, Le Chesnay, France
| | | | | | - D Defez
- Centre Hospitalier Universitaire, Lyon, France
| | - P Douek
- Centre Hospitalier Universitaire, Lyon, France
| | - V Gaxotte
- Hôpital Bichat, AP-HP, Paris, France
| | | | - S Leygnac
- Hôpital Bichat, AP-HP, Paris, France
| | - P Ou
- Hôpital Bichat, AP-HP, Paris, France
| | | | - C Salvat
- Hôpital Lariboisière, AP-HP, Paris, France
| | | | - M Sirol
- Hôpital Lariboisière, AP-HP, Paris, France
| | - B Aubert
- Institut de Radioprotection et de Sureté Nucléaire, PRP-HOM/SER, BP17, Fontenay-aux-Roses 92262, France
| |
Collapse
|
38
|
Petroni T, Zaman A, Georges JL, Hammoudi N, Berman E, Segev A, Juliard JM, Barthelemy O, Silvain J, Choussat R, Le Feuvre C, Helft G. Primary percutaneous coronary intervention for ST elevation myocardial infarction in nonagenarians: a multicenter study. J Am Geriatr Soc 2015; 63:384-6. [PMID: 25688612 DOI: 10.1111/jgs.13264] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022]
Affiliation(s)
- Thibaut Petroni
- Cardiology Institute, Hôpital Pitié-Salpêtrière, Assistance Publique - Hôpitaux de Paris, Université Pierre-et-Marie-Curie, Paris, France
| | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
39
|
Georges JL, Moutacalli Maaroufi Z, Ajlani B, Blicq E, Gibault-Genty G, Sarfati L, Brami M, Charbonnel C, Legriel S, Livarek B. 0066: Identification of patients surviving out-of-hospital cardiac arrest who might benefit from early percutaneous coronary intervention. Archives of Cardiovascular Diseases Supplements 2015. [DOI: 10.1016/s1878-6480(15)71793-3] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/24/2022]
|
40
|
Blicq E, Georges JL, Elbeainy E, Gibault-Genty G, Benjemaa K, Jerbi B, Livarek B. Detection of Stent Underdeployment by StentBoost Imaging. J Interv Cardiol 2014; 26:444-53. [PMID: 24106743 DOI: 10.1111/joic.12062] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/17/2022] Open
Abstract
OBJECTIVE To evaluate the additional value of StentBoost® (SB), a motion-corrected X-ray technique that enhances stent visualization, for the assessment of stent deployment and procedure optimization during routine percutaneous coronary interventions (PCI). BACKGROUND Underdeployment and malapposition of stents during PCI may lead to in-stent thrombosis and restenosis. Coronary angiography (CA) is of limited value for the assessment of stent deployment. Intravascular ultrasound and optical imaging techniques are the gold standard, but are used in <10% of routine PCIs. METHODS We retrospectively analyzed 260 coronary lesions treated by stent implantation and assessed by SB during 168 consecutive PCI procedures. The immediate results of SB analysis and CA were assessed by 2 independent interventional cardiologists and compared. RESULTS A total of 275 stents were implanted; 45% were drug-eluting stents (DES). Direct stenting was performed in 78%. Results of SB and angiography were concordant for 210 lesions: 194 stents were correctly deployed (75%) and 16 were underdeployed (6%), shown by both techniques. In 47 patients (18%), SB detected an underdeployment of the stent whereas the angiographic result was good. Postdilatation was performed on the basis of SB in 89% of these cases. The additional contribution of SB was higher for left main lesions and for DES, and was not affected by coronary calcifications. CONCLUSIONS This study confirmed the usefulness of the stent visualization enhancement technique StentBoost® in current PCI practice. SB revealed about 20% underdeployed stents not detected by CA, and allowed for optimizing PCI by ad hoc effective postdilatation.
Collapse
Affiliation(s)
- Elodie Blicq
- Service de Cardiologie, Centre Hospitalier de Versailles, Hôpital André Mignot, Le Chesnay, France
| | | | | | | | | | | | | |
Collapse
|
41
|
Georges JL, Belle L, Ricard C, Cattan S, Albert F, Hirsch JL, Monsegu J, Dibie A, Khalife K, Caussin C, Maccia C, Livarek B, Hanssen M. Patient exposure to X-rays during coronary angiography and percutaneous transluminal coronary intervention: Results of a multicenter national survey. Catheter Cardiovasc Interv 2014; 83:729-38. [DOI: 10.1002/ccd.25327] [Citation(s) in RCA: 34] [Impact Index Per Article: 3.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 06/17/2013] [Revised: 10/24/2013] [Accepted: 11/28/2013] [Indexed: 11/07/2022]
Affiliation(s)
- Jean-Louis Georges
- Service de Cardiologie; Centre Hospitalier de Versailles; Le Chesnay France
- College National des Cardiologues des Hopitaux; Paris France
| | - Loic Belle
- College National des Cardiologues des Hopitaux; Paris France
- Service de Cardiologie and RENAU; Centre Hospitalier d'Annecy; Annecy France
| | - Cécile Ricard
- Service de Cardiologie and RENAU; Centre Hospitalier d'Annecy; Annecy France
| | - Simon Cattan
- College National des Cardiologues des Hopitaux; Paris France
| | - Franck Albert
- College National des Cardiologues des Hopitaux; Paris France
| | - Jean-Lou Hirsch
- College National des Cardiologues des Hopitaux; Paris France
| | - Jacques Monsegu
- College National des Cardiologues des Hopitaux; Paris France
| | - Alain Dibie
- College National des Cardiologues des Hopitaux; Paris France
| | - Khalife Khalife
- College National des Cardiologues des Hopitaux; Paris France
| | | | - Carlo Maccia
- Service de Cardiologie; Centre Hospitalier de Versailles; Le Chesnay France
| | - Bernard Livarek
- Service de Cardiologie; Centre Hospitalier de Versailles; Le Chesnay France
- College National des Cardiologues des Hopitaux; Paris France
| | - Michel Hanssen
- College National des Cardiologues des Hopitaux; Paris France
| | | |
Collapse
|
42
|
Charbonnel C, Convers-Domart R, Pesenti-Rossi D, Baron N, Deleuze P, Georges JL, Livarek B. [Undifferentiated sarcoma: usefulness of multimodality cardiac imaging in characterizing a rare intracardiac mass]. Ann Cardiol Angeiol (Paris) 2013; 62:347-350. [PMID: 24112712 DOI: 10.1016/j.ancard.2013.08.016] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/09/2013] [Accepted: 08/12/2013] [Indexed: 06/02/2023]
Abstract
We report the case of a man presenting with a Pierre Marie-Bamberger syndrome. This paraneoplastic syndrome revealed an undifferentiated intracardiac sarcoma. This case emphasizes the need for multimodality imaging to characterize intracardiac tumor.
Collapse
Affiliation(s)
- C Charbonnel
- Service de cardiologie, centre hospitalier de Versailles, 177, rue de Versailles, 78157 Le Chesnay, France.
| | | | | | | | | | | | | |
Collapse
|
43
|
Pesenti Rossi D, Baron N, Georges JL, Livarek B. Intra-Aortic Coronary Stent Fracture Revealed by Stent Boost Imaging and Confirmed by Multislice Computed Tomography. JACC Cardiovasc Interv 2013; 6:202-3. [DOI: 10.1016/j.jcin.2012.08.025] [Citation(s) in RCA: 7] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 04/23/2012] [Revised: 07/23/2012] [Accepted: 08/02/2012] [Indexed: 11/29/2022]
|
44
|
Georges JL, Belle L, Khalife K, Filippi-Codaccioni E, Jouve B, Pecheux M, Tabone X, Caussin C, Bru P, Maccia C, Cattan S, Hanssen M. 033: New reference levels for radiation doses to patients undergoing coronary angiography and coronary percutaneous interventions: the RAY ACT study. Archives of Cardiovascular Diseases Supplements 2013. [DOI: 10.1016/s1878-6480(13)70963-7] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/25/2022]
|
45
|
Georges JL, Pesenti-Rossi D, Livarek B. Controlling the radiation dose received by patients undergoing cardiac imaging. Future Cardiol 2010; 7:1-5. [PMID: 21174504 DOI: 10.2217/fca.10.117] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/21/2022] Open
|
46
|
Georges JL, Livarek B, Gibault-Genty G, Aziza JP, Hautecoeur JL, Soleille H, Messaoudi H, Annabi N, Kebsi MA. Reduction of radiation delivered to patients undergoing invasive coronary procedures. Effect of a programme for dose reduction based on radiation-protection training. Arch Cardiovasc Dis 2010; 102:821-7. [PMID: 19963193 DOI: 10.1016/j.acvd.2009.09.007] [Citation(s) in RCA: 42] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 06/03/2009] [Revised: 09/25/2009] [Accepted: 09/28/2009] [Indexed: 11/28/2022]
Abstract
BACKGROUND Exposure of patients to radiation from invasive cardiac procedures is high and may be deleterious. AIMS To assess the effectiveness of a dose-reduction programme based on radiation-protection training, according to the recommendations of the Euratom Council, the International Commission on Radiological Protection and the French Society of Cardiology. METHODS In this single-centre survey, dose-area product (DAP, Gy.cm(2)), fluoroscopy time (minutes) and number of runs were evaluated in 3285 consecutive procedures (2077 coronary angiographies [CAs], 1208 percutaneous coronary interventions [PCIs]), performed one year before (2005) and two years after (2006 to 2007) implementation of a programme for radiation dose-reduction. The programme included a 2-day training course in radiological protection for all medical and paramedical staff and recommendations for routine use of low fluoroscopic and acquisition pulse rates (6.25 and 12.5 i/s, respectively), large field size (23cm), maximal collimation and optimal X-ray tube/patient/detector distances. Routine left ventriculography was discouraged. The radial approach was used in>80% of the procedures. RESULTS Compared with 2005, a significant 50% reduction in DAP was observed in 2006 and 2007 during CA (median [interquartile range] 53 Gy.cm(2) [33-84] vs 26 [16-43] and 21 [14-32], respectively; p<0.0001) and PCI (125 Gy.cm(2) [78-184] vs 49 [31-79] and 44 [27-66], respectively; p<0.0001). Fluoroscopy time and number of runs did not vary significantly in 2006, and decreased slightly in 2007, likely due to an important reduction in rate of left ventriculographies (from 32 to 4%). Inter-operator variability in DAP was reduced. CONCLUSION Training in radiation protection for interventional cardiologists and use of simple and cost-free dose-reduction techniques were associated with a 50% reduction in radiation exposure to patients undergoing invasive cardiac procedures, without any loss of diagnostic information.
Collapse
Affiliation(s)
- Jean-Louis Georges
- Service de cardiologie, centre hospitalier de Versailles, hôpital André-Mignot, 177, rue de Versailles, 78150 Le Chesnay, France.
| | | | | | | | | | | | | | | | | |
Collapse
|
47
|
Durand E, Hamm C, Macaya C, Georges JL, Coste P, Wolf J, Slama M, Husted S, Mosseri M, Lafont A. A randomised controlled trial of upstream administration of eptifibatide in patients presenting non-ST segment elevation acute coronary syndrome treated with an invasive strategy. EUROINTERVENTION 2007; 3:228-34. [DOI: 10.4244/eijv3i2a39] [Citation(s) in RCA: 7] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/23/2022]
|
48
|
Georges JL, Livarek B, Gibault-Genty G, Messaoudi H, Aziza JP, Hautecoeur JL, Soleille H. [Variations of radiation dosage delivered to patients undergoing interventional cardiological procedures. A monocentric study 2002-05]. Arch Mal Coeur Vaiss 2007; 100:175-81. [PMID: 17536420] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 05/15/2023]
Abstract
X-ray exposure of patient during coronary angiography (CA) and percutaneous transluminal coronary angioplasty (PTCA) may have some deleterious effects. The dose area product (DAP), related to the effective dose, is a measure of stochastic risk and a potential quality indicator. The aim of our study was to assess radiation exposure of patients in a large series of "real life" interventional cardiac procedures. We evaluated DAP and Fluoroscopy time (t) during CA and/or PTCA in 3600 consecutive patients from 2002 to 2005. Procedures were performed by five experienced physicians, using successively femoral and radial techniques. DAP and t significantly correlated (r = 0.73; p < 0.0001). Median [25th-75th percentiles] values for DAP and for t were 63 [40-101] Gy.cm2 and 6.3 [4-10] min for CA, 100 [62-178] Gy.cm2 and 14.0 [9-22] min for elective PTCA, and 141 [90-219] Gy.cm2 and 15.7 [11-23] min for CA immediately followed by ad hoc PTCA, respectively. Differences between operators ranged from 50% (CA) to 70% (PTCA) for both DAP and t (p < 0.001). Moving from the femoral to the radial approach resulted in a 1.5 to 2-fold increase in DAP in 2002 (p < 0.001). DAP and t then decreased toward the european DIMOND reference values (in 2005: 53.4 Gy.cm2 and 5.5 min for CA, 104.64 Gy.cm2 and 13.1 min for elective PTCA, 128.4 Gy.cm2 and 13.6 min for ad hoc PTCA). In conclusion, radiation exposure to patients and staff are strongly dependent on operators, time course, and the arterial access, due in part to the learning curve for radial approach. The enhanced knowledge of radiation dose is the first step of a radiation dose-reduction program, likely to minimize patient and operator radiation hazards in interventional cardiology. Definition of national reference values for DAP and fluoroscopy time would be helpful for appropriate comparisons.
Collapse
Affiliation(s)
- J L Georges
- Service de cardiologie, centre hospitalier de Versailles, hôpital André-Mignot, Le Chesnay.
| | | | | | | | | | | | | |
Collapse
|
49
|
Georges JL, Loukaci V, Poirier O, Evans A, Luc G, Arveiler D, Ruidavets JB, Cambien F, Tiret L. Interleukin-6 gene polymorphisms and susceptibility to myocardial infarction: the ECTIM study. Etude Cas-Témoin de l'Infarctus du Myocarde. J Mol Med (Berl) 2001; 79:300-5. [PMID: 11485024 DOI: 10.1007/s001090100209] [Citation(s) in RCA: 133] [Impact Index Per Article: 5.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/08/2023]
Abstract
There is growing evidence that interleukin (IL) 6 plays an important role in the atherosclerotic process because of its role in mediating immune and inflammatory responses and inducing cell proliferation. The present study examined whether molecular variations at the IL-6 locus are involved in the predisposition to myocardial infarction. The entire coding region, 1,158 bp of the 5' flanking region and 237 bp of the 3' flanking region of the IL-6 gene were screened. We detected three nucleotide substitutions in the 5' region at positions -174 (G/C), -572 (G/C), and -596 (G/A) from the transcription start site, and one insertion/deletion in the 3' region at position +528 after the Stop codon. These polymorphisms were genotyped in the Etude Cas-Témoin de l'Infarctus du Myocarde study comparing male patients (n=640) and age-matched controls (n=719) from Northern Ireland and France. The IL-6/G-174C and IL-6/G-596A polymorphisms were in nearly complete association. Carriers of the IL-6/-174 C allele were more frequent in patients than in controls. The population-adjusted odds ratio for myocardial infarction associated with genotype CC+CG vs. GG was estimated as 1.34. In French patients the number of coronary arteries with greater than 50% stenosis was assessed by angiography. The IL-6/-174 C allele was more frequent in patients with two or fewer stenosed vessels than in patients with three-vessel lesions. These results suggest that genetic variation at the IL-6 locus is associated with susceptibility to myocardial infarction, especially events occurring on less extended lesions. These findings would be compatible with a lower IL-6 secretion associated with the IL-6/-174 C allele, itself or in combination with other promoter polymorphisms, leading to more unstable plaques.
Collapse
Affiliation(s)
- J L Georges
- INSERM U525, Faculté de Médecine, Paris, France
| | | | | | | | | | | | | | | | | |
Collapse
|
50
|
Donger C, Georges JL, Nicaud V, Morrison C, Evans A, Kee F, Arveiler D, Tiret L, Cambien F. New polymorphisms in the interleukin-10 gene--relationships to myocardial infarction. Eur J Clin Invest 2001; 31:9-14. [PMID: 11168433 DOI: 10.1046/j.1365-2362.2001.00754.x] [Citation(s) in RCA: 53] [Impact Index Per Article: 2.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 12/22/2022]
Abstract
BACKGROUND Interleukin-10 (IL-10) is a cytokine with anti-inflammatory and B-cell-stimulating activity. IL-10 is expressed in human atherosclerotic plaques and recent studies have shown the involvement of IL-10 in the atherosclerotic process. Therefore, we hypothesized that polymorphisms in the IL-10 gene might be associated with a predisposition to coronary heart disease. MATERIALS AND METHODS To identify new polymorphisms in the human IL-10 gene, the entire coding sequence and the 3' flanking sequence of the gene were screened by polymerase chain reaction-single strand conformation polymorphism (PCR-SSCR) followed by sequencing. The polymorphisms identified, and three others which have been previously described in the promoter region of the IL-10 gene (G-1082A, C-819T, C-592A), were then investigated in the ECTIM Study, a large population-based case-control study of myocardial infarction. RESULTS Four new polymorphisms were identified: one in exon 1 (G+78/ex1A), which predicts a Glycine to Arginine change at position 15 in the putative signal peptide of the protein, two in the intron 3 (C+19/in3T, T+953/in3C) and one in the 3' flanking region (C+117T). All the IL-10 polymorphisms were in complete or nearly complete pairwise linkage disequilibrium. No case-control difference was found in genotype or allele frequencies for any of the polymorphisms. CONCLUSIONS Our results suggest that IL-10 polymorphisms are not associated with an increased risk of myocardial infarction.
Collapse
|